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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
In the late 1980s, a dramatic and often devastating disease pattern emerged in North 
America and Europe almost simultaneously and was characterized by abortion storms, fever, 
and lethargy in reproductive age animals and by severe pneumonia, fever, anorexia, and 
increased mortality in growing pigs. Veterinarians and diagnosticians dubbed this newly 
emerged complex the "mystery swine disease" and, although the name has been changed, it 
is still in many ways a mystery disease. Now, nearly twenty years later, even though much 
has been learned about the causative agent of this syndrome, the porcine reproductive and 
respiratory syndrome virus (PRRSV), this disease continues to be difficult to prevent and 
control among swine herds in nearly every region of the world. Some infected herds remain 
relatively stable while others go through periodic epizootics with high reproductive and 
nursery losses. A recent trend in breeding and production herds alike has been eradication of 
PRRSV from the entire production system, and although many are successful in eliminating 
the virus initially, there are reports of re-breaks despite intense biologic security in and 
around the farms. In addition to the epidemiologic hurdles to overcome with PRRSV, there 
is at present no vaccine that is completely safe and protective for general use in all 
production situations. 
The PRRS virus frequently mutates and differences in virulence between sequence 
variants of PRRSV has been demonstrated experimentally (Halbur et al., 1996), but the 
differences may not fully explain the variation in disease severity observed under field 
conditions. Varying levels of susceptibility to a single strain of PRRSV among pigs in the 
same population have been observed in naturally and experimentally infected animals 
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(Halbur et al., 1998), as well as with macrophages infected in vitro (Molitor et al., 1996; 
Voicu et al., 1994). This would suggest that there is underlying genetic variation in 
susceptibility to PRRSV. If a genetic mode of susceptibility to PRRSV could be identified, 
there is potential for selection of pigs that possess increased resistance to this economically 
important disease. Genetic improvement would be further advanced by identification of 
genes or genetic markers related to resistance to PRRSV. 
Multiple reports provide evidence of inherited resistance to infectious organisms and, 
in some instances, breeding and selection has been used to develop breeds or strains that 
exhibit the resistant or susceptible phenotype. Much of this work has been done in laboratory 
animal species, but recent advances in mapping and sequencing the genomes of domestic 
livestock species now make the parallel work in these animals plausible. Although many of 
the published reports on disease resistance genes in pigs are single genes with simple 
Mendelian inheritance, the potential exists for improvement of complex diseases via 
identification of genes or chromosomal regions having major impact on the disease 
phenotype. As we develop a better understanding of the pathogenesis of PRRSV and the 
requirements of an effective immune response for protection in the pig, it is important to 
continue to investigate the genetic components of pathogen and host that confer the 
characteristics of virulence and resistance. 
The first step to begin searching for genetic resistance to PRRSV is to identify 
populations that express variation in susceptibility to a single isolate of virus. Our objectives 
in the studies described herein were to first evaluate the use of an antemortem in vitro test as 
an indicator in identifying commercial breeding stock lines with high and low susceptibility 
to PRRSV and, second, to evaluate the pigs from lines selected from the first objective in an 
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experimental infection model. Macrophages have been shown to be the cell type PRRSV 
preferentially infects and subsequently manipulates to achieve efficient replication and 
production of progeny virions. The in vitro assay was therefore designed to evaluate the 
percentage of macrophages derived from peripheral blood monocytes that are susceptible to 
infection in culture by PRRSV. In order to address objective one, six genetically diverse 
lines of pigs maintained as commercial breeding seed-stock were evaluated for differences in 
their in vitro susceptibility to PRRSV. The specific aim of objective one was to determine if 
the in vitro PRRSV flow cytometric assay could be utilized to detect the existence of genetic 
variability in the susceptibility of the host to PRRSV infection. From the results of the six 
screened lines, two genetically distinct lines with opposing in vitro results were selected for 
further study to confirm the results of the antemortem in vitro assay screening. 
The second objective was to infect pigs from lines demonstrated to have high and low 
susceptibility in the in vitro assay in order to evaluate variation of disease traits in vivo. The 
average percentage of PRRSV-infected macrophages in culture was shown to differ 
statistically between the two chosen lines, indicating that the susceptibility of macrophages in 
culture varied. To investigate these differences in vivo, PRRSV challenge studies were 
conducted in four independent replicates. Pigs were experimentally infected and evaluated 
for disease susceptibility using a flow cytometric assay, clinical presentation of respiratory 
disease, macroscopic lesions, microscopic lesions, and virus titers in serum and lung lavage 
fluid. The overall aim of the investigations reported here were to provide evidence for a 
genetic basis to susceptibility to PRRSV-induced infection and disease utilizing both an in 
vitro PRRSV susceptibility assay and experimental challenge and to evaluate the usefulness 
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of the in vitro flow cytometric assay in predicting susceptible and resistant populations upon 
challenge. 
Dissertation Organization 
This dissertation is written in the alternative format. Following the introduction is a 
review of current literature. The next chapters are the author's research, in manuscript 
format prepared for publication. A discussion of the implications of this work is given in the 
general conclusions. The citations from the introduction, literature review, and general 
conclusions sections are compiled in the reference list at the end of the dissertation. 
Literature Review 
Genetics and Infectious Disease 
Although breeding and selection of livestock animals, including swine, has 
traditionally focused on production traits, there has been a recent surge of interest in using 
modern genetic tools to select animals with increased resistance to important pathogens. The 
concept of genetics being linked to infectious diseases, however, is not a new one and was 
first alluded to by Charles Darwin in his evolutionary theory. J. B. S. Haldane took Darwin's 
concept of natural selection a step further and proposed that infectious diseases can alter the 
frequencies of the very genes that are responsible for controlling the infection in the host 
(Haldane, 1959). Some have argued that if alleles that confer resistance to important diseases 
lead to enhanced survival, these favorable alleles will become fixed in the population (Stear 
et al., 2001). However, the existence of variability in genes that confer protection against 
important pathogens can be explained by several events of population genetics and selection. 
The first mechanism that can bring about change in genes that are responsible for 
disease resistance is through mutation, whereby individuals with favorable genotypes created 
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by random mutations survive to reproductive age by resisting pathogens that cause disease. 
For these pathogens to exert pressure on gene frequencies, it is necessary that they cause 
diseases with high morbidity and/or mortality, occur before reproductive maturity, and that 
the disease exerts pressure over long periods of time (Cooke and Hill, 2001). The most 
recognized example of this type of evolution in humans is malaria. The red blood cell 
disorders of sickle cell anemia and a- and ^-thalassemias, as well as polymorphisms at the 
Duffy antigen, each have been identified at a higher incidence in human populations co­
existing with the Plasmodium species that cause malaria (Cooke and Hill, 2001; Dean et al., 
2002). 
A related concept to explain the existence of variability in genes that confer disease 
resistance is through mutations that were selected for resistance to previously important 
pathogens may confer resistance to a newly emerged pathogen that shares similar molecules 
in its infectious pathways (Dean et al., 2002). This has been proposed to be one possible 
mechanism of resistance to human immunodeficiency virus (HIV) that is due to a 32 base 
pair deletion in the chemokine receptor gene CCR5 (CCR5A32). The CCR5A32 genotype is 
found in higher frequencies in Caucasian populations. The mutation has been shown to 
confer partial to complete protection against infection for homozygous individuals and a 
slower rate of progression to the clinically apparent acquired immunodeficiency syndrome 
(AIDS) in hétérozygotes. This recently emerged disease appears to have originated in 
Africa, however, the CCR5À32 mutation is not found in African or most Asian populations. 
It is unlikely that HIV was the selecting force for the increased frequency of this mutation 
due to its relatively recent entry into the human population within the last 100 years. 
However, some authors have suggested Yersinia pestis as the selecting force that maintained 
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the mutation in populations, possibly through the shared use of CCR5 as a receptor or co-
receptor for pathogen entry into macrophages (Sullivan et al., 2001). The connection 
between Y. pestis and CCR5A32 came through the calculated origin of the mutation, which is 
proposed to have occurred during the time frame of the plague epidemics in Europe. The 
relatively high frequency of this mutation in ethnic populations that would have been 
affected by the major plague epidemics further suggests the association between the 
CCR5À32 genotype and resistance to infection by Y. pestis (Libert et al., 1998). 
The third explanation for the existence of variation in resistance genes in domestic 
livestock populations is through modern breeding and production practices. The majority of 
the selection in livestock species in the past has been focused on improving production or 
reproduction traits. Genetic variation associated with disease traits may be maintained if the 
genes also have a pleiotrophic effect on production or reproduction traits or if they are simply 
in linkage disequilibrium with loci that have been selected through modern breeding schemes 
(Stear et al., 2001). In addition, modern management practices may reduce selective pressure 
on disease resistance traits through the control of animal flow and population density and the 
use of vaccines or pharmaceuticals, all of which may allow favorable and unfavorable alleles 
to segregate in a more random fashion. Additionally, certain alleles may be favored in 
different environments or in the presence of other diseases, allowing distinct populations or 
subpopulations to maintain the divergent alleles. 
Finally, many disease resistant traits have been associated with the major 
histocompatibility complex (MHC), also known as the leukocyte antigen complex (SLA for 
swine, HLA for human, BoLA for bovine) (Lunney, 1994; Renard et al., 2001). These 
chromosomal complexes of multiple genetic loci are intimately associated with immune cell 
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function through self- and non-self recognition and immune activation. In addition, the 
MHC contains the most polymorphic genes known, the MHC class I and MHC class II 
genes. On a population level, heterozygosity at the MHC chromosomal region has been 
shown to be advantageous. The heterozygote advantage against the diverse spectrum of 
pathogens a species will encounter, especially those capable of rapid mutation, has likely 
maintained the high level of variation in the alleles at the MHC loci. In addition, increased 
susceptibility for multiple diseases has been demonstrated in populations with limited MHC 
diversity. Although most immune responses to infectious agents are multi-factorial, it is 
clear that multiple genes within the MHC are associated with various infectious diseases 
(Dean et al., 2002). 
To strengthen the argument that variability exists in genes that confer protection 
against pathogens in pigs and other livestock species, many examples can be found in the 
literature to demonstrate associations between either specific genes or chromosomal regions 
known as quantitative trait loci (QTL) and resistance to infectious diseases. In addition, there 
are a number of disease-association studies that have identified specific populations, breeds, 
or strains with increased or decreased susceptibility to infection. This literature review will 
restrict itself primarily to outbred populations of mammals, with a special emphasis on work 
done with pigs. Although there is a wealth of evidence for genetic resistance to infectious 
organisms in lab animal species such as the mouse, it is often difficult to extrapolate findings 
from mice to outbred species and these rodent studies are reviewed elsewhere. In an effort to 
categorize the associations between genetics and disease resistance, the immune system can 
be broken down on a basic level into innate (natural) or acquired (adaptive) barriers to 
infection. In reality, the two exist as a continuum, with the innate system signaling or 
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activating the adaptive system when the primary barriers are overcome. However for 
simplicity, this review will categorize the two as separate entities with each system having 
multiple and sometimes overlapping defense mechanisms against pathogens. The innate 
defenses can be described as those that prevent or control the establishment of infection 
whereas the adaptive immune system responds and controls or eliminates an established 
infection through specific and qualitative responses (Doenhoff, 2000). Diseases with genetic 
associations can also be classified by the type of organism that causes the disease, and the 
type of organism is often related to which arm of immune response that is most effective. 
Genetic associations have been described for a wide range of pathogens and parasites, 
including viruses, prions, bacteria, protozoa, helminths, and arthropods. 
Genes and genetic associations within the innate immune system 
The first barrier of the natural host defense against pathogens is the epithelial cell 
layer of mucous membranes, the mucociliary apparatus of the respiratory system, and the 
skin. The second barrier is the generalized rapid anti-foreign system of recognition by cells 
of the innate immune system which include macrophages, neutrophils, natural killer cells, 
and dendritic cells. The second barrier also includes components of the complement system 
that opsonize and/or destroy blood borne microbes and the type I interferons that control viral 
infections. A limited number of single gene mutations falling into the innate category have 
been correlated with resistance or susceptibility in outbred populations of mammalian 
species. These genes tend to be related with either receptors on the surface of the host cell 
necessary for establishment of infection or with molecules involved in phagocyte killing. In 
humans, there are several well-characterized receptors associated with disease resistance. As 
described above, a 32 base pair deletion in the CCR5 gene confers resistance to HIV (Cooke 
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and Hill, 2001). CCR5 acts as a co-receptor for the entry of HIV into macrophages and is 
important in the early stages of infection. Individuals homozygous for the CCR5A32 alleles 
exhibit much higher levels of resistance while heterozygotes have delayed progression to 
AIDS. Other well-known examples of genetic variation in receptors used by pathogens 
include blood group antigens and the Duffy antigen (also known as DARC), which seem to 
play a role in Plasmodium entry into erythrocytes (Dean et al., 2002). 
In pigs, receptors in the intestinal lumen have been identified for different antigenic 
strains of Escherichia coli that cause neonatal diarrhea and post-weaning diarrhea and edema 
disease (Francis et al., 1999; Jin and Zhao, 2000). The fimbrial antigens (K or F antigens) 
from different enteropathogenic or enterotoxigenic E. coli variants contributes to the 
adherence of the organisms based on age and/or tissue specific molecules in the small 
intestine of growing pigs. The K88-positive E. coli are largely responsible for neonatal 
diarrhea in pigs whereas the F18-positive E. coli tend to cause diarrhea and edema disease in 
older pigs (Edfors-Lilja and Wallgren, 2000). The specific recognition sites on intestinal 
receptors for enterotoxigenic K88 and F18 variants have been demonstrated to be 
carbohydrate structures expressed on host cell surface lipids or proteins (Jin and Zhao, 2000; 
Grange et al., 2002). 
Three major antigenic E. coli types causing neonatal diarrhea have been identified as 
K88ab, K88ac, and K88ad. The K88ab and K88ac receptors are inherited in simple 
Mendelian fashion with the favorable alleles being recessive (Sellwood et al., 1975). A 
glycoprotein belonging to the transferrin family has been shown to be a receptor for K88ab 
(Grange and Mouricout, 1996), a pair of mucin-type sialoglycoproteins as receptors for 
K88ab and K88ac, and a glycosphingolipid for K88ad (Francis et al., 1999). There are two 
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tightly linked genetic loci for the K88abR and the K88acR, both located on pig chromosome 
13 (SSC13) (Edfors-Lilja et al., 1995), although the precise genes and mutations have yet to 
be definitely identified. Recent work has better defined this area to within 4 microsatellite 
markers on SSC13q31 (Peelman, 1999). The inheritance pattern of K88adR and its 
chromosomal location are less well defined. 
In contrast to the enterotoxigenic E. coli strains that cause diarrhea in piglets, strains 
that predominately cause diarrhea and edema disease in older pigs have been identified as 
F18ab and FlSac antigenic groups. A Mendelian pattern of inheritance for the F1 SabR has 
also been described with susceptibility to adhesion being the dominant phenotype 
(Bertschinger et al., 1993). The FlSabR locus has been mapped to SSC6 (Vogeli et al., 
1996). A pair of polymorphisms in the ce-( 1,2) fucosyltransferase gene (FUT1) has been 
shown to be closely linked to the E. coli F18 receptor loci on SSC6ql 1 (Meijerink et al., 
1997). That study also demonstrated that an allele of one of the FUT1 polymorphisms 
(M307) co-segregated with F18 colonization with high linkage disequilibrium between FUT1 
and the F18 receptor phenotype in Landrace, Large White, Duroc, Hampshire, and Pietrain 
pigs. The M307 polymorphism within FUT1 is being used as a molecular marker for use in 
marker assisted selection in pigs in attempts to decrease production losses due to post-
weaning scours and edema disease. 
Once a pathogen has utilized its receptor for either adherence to or entry into the host, 
a course of infection is initiated and that, in return, elicits a course of response by the 
immune system. One of the pivotal cell types involved in both pathogen killing and 
signaling to the adaptive immune system is the macrophage. The Natural Resistance-
Associated Macrophage protein 1 gene (NRAMP1, also SLC11A and Ity/Lsh/Bcg in mice) has 
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been associated with resistance to intracellular pathogens that infect macrophages, such as 
Salmonella, Mycobacterium, and Leishmania species in people, mice, chickens, and pigs. 
Nrampl is a proton/divalent cation antiport membrane protein expressed exclusively in 
macrophages and is thought to play a role in iron metabolism and in pathogen killing 
mechanisms specific to macrophages (Blackwell et al., 2003). Although still controversial, 
the precise function of the iron transport by Nrampl in the macrophage is thought to be by 
either providing iron as a catalyst for the production of oxygen and nitrogen reactive species 
and/or to deprive the pathogens of iron in the phagolysosomal compartment. Despite the 
controversy over its cellular activities, the NRAMP1 locus has long been associated with 
disease susceptibility to intracellular pathogens in mice (Skamene et al., 1982) and more 
recently in humans (Blackwell, 1998; Bellamy, 2003) and poultry (Hu et al., 1997; Kramer et 
al., 2003). Although NRAMP1 has been sequenced and mapped in the pig, there is no clear 
evidence of its association with resistance to Salmonella or other important intracellular 
pathogens in swine (Sun et al., 1998). 
In addition to the innate responses by macrophages to phagocytosed or intracellular 
bacteria, innate mechanisms to fight viral invaders exist in all cell types. One of the most 
potent antiviral responses in the innate immune system is the type I interferon response by 
infected cells. The type I interferons (IFN) have specific antiviral activities in addition to 
their inflammatory and stimulatory properties (Le Bon and Tough, 2002). Because of their 
role in defense against viruses, the interferon gene family was investigated in association 
with bovine herpesvirus type I or infectious bovine rhinotracheitis virus (IBRV) in cattle 
(Ryan et al., 1993; Ryan and Womack, 1997). These studies demonstrated associations 
between the severity of IBR-induced clinical disease, as measured by rectal temperatures, 
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feed intake, and growth traits, and three loci: IFNB1, IFNW4, and IFNW8, all mapped to 
bovine chromosome 8. It remains unknown which type I IFN gene may have been 
responsible for the reduction in disease severity and what contribution each of the alleles at 
the identified polymorphic sites had on the traits measured in those studies. 
The complement system is also an important mechanism of the innate immune 
system. Complement is important both due to the cascade that results in bacterial killing and 
metabolites of the complement components that are important in opsonization. The porcine 
C3 gene was investigated for its role in the classical and alternative complement pathway of 
hemolysis in vitro (Mekchay et al., 2003). This study identified multiple polymorphisms 
within and flanking the C3 gene and demonstrated a significant correlation between C3 
genotypes and hemolytic complement activities in vitro. Although resistance against specific 
pathogens was not investigated in this study, it does suggest that investigation of the C3 gene 
may be relevant for resistance to organisms that are known to be susceptible to the 
complement pathway. 
The importance of recognition of non-self by the innate immune system is becoming 
increasingly apparent with recent advancements in the field of pattern recognition receptors 
(PRR) and antimicrobial peptides (AMP) (Ganz, 2003; Underbill, 2003). Toll-like receptors 
(TLR) are a family of highly conserved PRRs that are present in multiple types in 
mammalian species and are important in recognition of particular motifs. These biochemical 
motifs are characteristic of certain classes of pathogens and include lipopolysaccharide 
(LPS), CpG DNA, double stranded RNA, lipoproteins and more. TLRs play a role in 
outside-in signaling for recognition of the foreign invader, followed by rapid inside-out 
signaling in macrophages and dendritic cells. The responses made by the macrophages and 
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dentritic cells link the innate immune system to the adaptive immune system through 
signaling pathways. Antimicrobial peptides appear to be another highly conserved 
mechanism of innate recognition and killing of foreign invaders. The AMP s are expressed 
on mucosal surfaces and are upregulated in response to microbial invasion. Despite the 
increased understanding of the importance of these types of molecules in early responses to 
infection, evidence is lacking for genetic variation within these loci and association between 
the loci and disease traits. Whether this is due to their highly conserved and constitutive 
nature or to the relatively recent description of their existence in mammals remains to be 
determined. 
Genes and genetic associations within the adaptive immune system 
The porcine immune system, although not as well characterized, is highly analogous 
to other mammalian species. However, there are some important species-specific differences 
in the development and characterization of the cells of the adaptive response in pigs. The B-
cell antibody repertoire is generated by various mechanisms in mammals including 
combinatorial rearrangement of immunoglobulin gene segments, junctional diversity at the 
borders between combined gene segments, the pairing of a rearranged K- or X-light chain 
with a rearranged heavy chain, templated gene conversion, and non-templated point mutation 
or somatic hypermutation (Butler, 1998; Janeway, 2001). The pig has a limited number of 
gene segments for antigen independent rearrangement in the development of naïve B-cells as 
compared to other species. Expression appears to be limited to five Vh segments, two Dh 
segments, and only one Jh segment in the variable region of the heavy chain genes in fetal 
and  neona ta l  p igs  (S inkora  e t  a l . ,  2002) .  Less  i s  known regard ing  the  va r i ab le  r eg ion  o f  K -
and X-light chain genes in pigs, although they appear to be expressed in approximately equal 
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proportions. It has been suggested that pigs utilize both somatic hypermutation and gene 
conversion as mechanisms of generating further antigen-dependent diversity in secondary 
lymphoid tissues. In swine, the predominant heavy chain isotype in serum and colostrum is 
IgG, whereas IgA predominates in milk, saliva, and the intestine. IgG and IgA are present in 
relatively equal proportions in the respiratory tract as demonstrated in bronchoalveolar 
lavage fluid (BAL) (Butler, 1998). 
Pigs also possess several unique characteristics in their T-lymphocyte subpopulations 
as well. There are multiple phenotypically distinct subpopulations of T cells that also differ 
in tissue distribution and function (Saalmuller, 1998; Saalmuller et al., 1999). Extra-thymic 
CD4CD8" double-negative and CD4+CD8+ double-positive T cells can both be found in the 
periphery. The double-negative T cells do not express the 0)3-T cell receptor (TCR), but 
rather express the 7Ô-TCR that is common in swine and other ungulates. The double-
negative 7Ô-TCR population is heterogeneous and contains several subsets including CD2+ 
and CD2" subsets of cells. The double-negative 7Ô-TCR populations are not MHC restricted 
and are present in higher numbers in young animals and in gut associated tissues. In contrast, 
the double-positive T cells are found in higher numbers in older animals, are significant in 
antigen-specific secondary responses, and are MHC II restricted. The CD4+CD8+ double-
positive T cells are also CD2+ and express the 048-TCR. The CD4+CD8" single-positive 
subpopulation tends to be more homogeneous and co-expresses CD2. This population 
expresses the a|3-TCR, is MHCII restricted, and is the classic T helper (Ty) subset. The CD4" 
CD8+ single-positive subpopulation is more heterogeneous in the amount of CD8 expressed 
and in the co-expression of CD2 and other surface markers. The CD8hlgh+ population is 
MHC I restricted whereas the CD8low+ is not. Both CD8 single-positive subsets display 
cytotoxic T lymphocyte (CTL) properties. 
Adaptive immune responses to pathogens have also been explored for potential 
genetic links between the molecules involved in adaptive responses and disease outcomes. 
The adaptive immune response involves highly specific recognition systems generated by B 
and T lymphocytes which discriminate more precisely between self and non-self through 
interactions between different subsets of lymphocytes and antigen presenting cells (APC) as 
compared to the innate system (Janeway, 2001). The B cell's antigen recognition molecule is 
the antibody, and B cell activation and production of antibody is known as the humoral 
response. T cell receptors are the antigen recognition molecules of T cells, and T cell 
activation through the TCR and production of signaling molecules is known as the cell 
mediated response. The discrimination between self and non-self occurs largely by the 
discrete activation of naïve lymphocytes to foreign antigen and elimination of auto-reactive 
cells. The activation in response to antigen is regulated through the interaction of the TCR 
and antigenic peptides presented by APCs in the context of MHC. It is through this complex 
and confounded system that the adaptive immune system is capable of recognizing and 
defending against the multitude of organisms that have developed strategies to evade the 
innate system. Although its complexity can be overwhelming, researchers have provided 
evidence for genetic links between molecules that participate in the adaptive immune system 
and disease resistance. 
The MHC class I and class II genes within the leukocyte antigen chromosomal 
complex are the most widely studied in association with disease resistance, especially in 
humans and chickens, and many HLA alleles or haplotypes have been associated with 
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infectious diseases. The MHC class I alleles have been associated with susceptibility and/or 
prognosis to diseases caused by intracellular microorganisms including HIV, Plasmodium 
spp., and Mycobacterium spp. (Cooke and Hill, 2001; Dean et al., 2002). More recently, a 
class I allele found in Taiwanese people was associated with clinically severe cases of severe 
acute respiratory syndrome caused by a newly emerged coronavirus (Lin et al., 2003). The 
MHC class II alleles have also been associated with a number of diseases in humans, 
including AIDS, Hepatitis B, Hepatitis C, Lyme's disease, malaria, tuberculosis, and leprosy. 
The SLA region in the pig is not as well characterized as that of man or other species. 
However, advances have been made in understanding the genetic composition of this region 
and the expression of both MHC class I and MHC class II genes located on SSC7 
(Rothschild et al., 2000). The number of classical MHC I genes in the class I region appears 
to be seven, although there are discrepancies in reports that may be due to differences 
between the pig populations studied (Chardon et al., 1999; Renard et al., 2001). Three of the 
seven MHC class I genes (SLA-1, -2, and -3) are expressed in most pig breeds, and multiple 
alleles at each of these loci have been identified in various inbred and outbred populations. 
Most of the amino acid variability between SLA Class I heavy chain proteins lie in the 
peptide binding groove or residues that interact with the TCR (Chardon et al., 1999; Ando et 
al., 2003). The class II genes are named with similar taxonomy to their human class II 
counterparts in the HLA, with functional DR «-chains, DR (31 chains, DQ «-chains, and DQ 
jS-chains expressed at the protein level (Baba et al., 1999; Chardon et al., 1999). Multiple 
studies have associated the MHC with generalized immune responses and resistance to a few 
infectious diseases in pigs (Lunney and Butler, 1998), but not to the precise level as the 
allelic studies done in humans. In addition to the advances in mapping the SSC7 SLA 
region, recent advances in technology now allow for rapid haplotyping of SLA genes using 
polymerase chain reaction (PCR) assays (Martens et al., 2003). The availability of 
haplotyping at the SLA class I and class II loci will enable us to further evaluate the role of 
the MHC region in disease outcomes from infectious agents important in swine populations. 
In addition to antigen presentation through the MHC to T cells, there are numerous 
other signaling pathways involved in the cell mediated immune response that have been 
shown to be critical in effective immune responses. An elegant picture of how functional 
elimination of key molecules involved in T cell immunity can be associated with infectious 
disease is now coming together through the combined efforts of researchers in human 
immunogenetics (Ottenhoff et al., 2002). The T-cell mediated pathway described in these 
studies involves a response to bacteria that invade and survive intracellularly in 
macrophages, such as mycobacteria and salmonellae. The infected macrophages require 
interaction from T cells for effective activation and killing, generally through cytokines of 
the type 1 T helper cell lineage (TrI). The interferon-7 (IFN-y) signaling pathway is critical 
for clearance of these organisms and the genetic associations between the molecules in this 
pathway and disease outcomes have been demonstrated most notably with tuberculosis. 
Ethnic differences in prevalence and death rates due to tuberculosis and leprosy have 
been observed for hundreds of years. However recent genomic studies have revealed many 
of the underlying causes of these population differences (Bellamy, 2003). Deleterious 
mutations in five different genes involved in the signaling pathway between T cells and 
macrophages have been identified, including the interleukin-12 p40 subunit, IL-12 receptor 
j31 subunit, IFN-y receptor 1 (IFN-yRl) subunit, IFN-yR2 subunit, and the signal transducer 
and activator of transcription 1 signaling molecule. Although many of the identified 
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mutations lead primarily to complete deficiencies of one of the five genes in the reported 
studies, the role of genetic variation resulting in minor amino acid substitutions in these and 
other genes involved in the IFN-7 pathway has yet to be fully explored in man or 
domesticated livestock species. Investigating the possible influence of variation in these 
genes on genetic susceptibility to infectious diseases in other hosts is indicated based on the 
important findings in these human studies. Since several Mycobacterium and Salmonella 
species are significant pathogens in swine, increasing resistance through genes in this 
pathway may be important in reducing morbidity and mortality, in addition to reducing the 
economic losses due to antibiotic usage and condemnation at slaughter. 
To complement the functional genomic strategies described above, reports can also be 
found in the literature of selecting and breeding pigs for overall immune-responsiveness as 
measured by various immune parameters (Mallard et al., 1992). The goal of this strategy was 
to increase the level of general resistance against many pathogens rather than a single 
infectious agent. Pigs were selected based on an index that included delayed-type 
hypersensitivity against tuberculin, serum antibody response to hen egg-white lysozyme 
(HEWL), polyclonal lymphocyte proliferation with concanavalin A, and serum IgG levels. 
From these selected animals, high responder, low responder, and control lines were 
maintained and subsequent vaccine and/or challenge studies were conducted. Post-exposure 
antibody responses to a variety of antigens were consistently higher in the high immune 
responder line, and, conversely, the frequency of non-responders was higher in the low 
responder line (Wilkie and Mallard, 2000). The quality of the antibody response also 
appeared to be greater in the high responder line with higher antibody avidity during the 
secondary response compared to the low responder line when immunized against HEWL 
(Appleyard et al., 1992). However, it was also demonstrated that the high responder 
phenotype was not consistently beneficial against all clinical signs of disease, especially 
when the host response contributes to the pathology of the disease. Pigs from the high 
response line and low response line were infected with Mycoplasma hyorhinis and evaluated 
for arthritis, pericarditis, pleuritis, and peritonitis (Magnusson et al., 1998). The severity of 
peritonitis and pleuritis were significantly lower in the high responder line, however the high 
responder challenged group had significantly more severe signs of arthritis. The high 
responder line has consistently been reported to have increased growth rates, suggesting an 
overall benefit to selecting for high immune responders. Caution should be taken, however, 
due to the M hyorhinis results and a lack of further challenge studies to document a superior 
outcome in other disease models. 
A limited number of published reports can be found in the literature regarding 
specific pathogens and differences between breeds of pigs in measurements of disease 
susceptibility. Pseudorabies virus (PRY), an alphaherpes virus, is the causative agent of 
Aujeszky's disease, a disease of importance worldwide causing lesions in both the central 
nervous and respiratory systems. Previous research had demonstrated differences in response 
to PRY vaccine (Rothschild et al., 1984) and in susceptibility to disease (Messing et al., 
1994). A recent report by Reiner, et al. (2002b) describes the use of an F; cross between 
susceptible (Large White) and resistant (Meishan) breeds to detect quantitative trait loci 
(QTL) associated with development of neurological signs and course of fever (Reiner et al., 
2002b). Neurological signs were associated with the Large White founder breed and 
appeared to have a dominant inheritance pattern. The neurological signs were associated 
with QTL on three chromosomes, temperature profiles were associated with QTL on seven 
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chromosomes, and the chromosomal locations appeared to be independent of one another for 
the two indicator traits. Two of the neurological sign QTLs were linked with genes identified 
to be important as receptors for the pseudorabies virus in a rodent model, but are as yet 
unknown in importance in pig infections. Other QTL were located near genes involved in 
the Thl cell mediated pathway including IL-12, IFN-7, and an IFN receptor. Further study is 
required to evaluate the role of the genetic markers and/or nearby candidate genes identified 
in this study in host susceptibility or resistance to pseudorabies in swine populations. 
Differences in susceptibility to protozoan diseases between purebred pigs have also 
been described (Reiner et al., 2002a). In this study, a small number of pigs from Meishan 
and Pietrain breeds were challenged with the protozoan parasite Sarcocystis miescheriana as 
a model for susceptibility to protozoan infectious disease in pigs. Differences in rectal 
temperatures, isotype specific antibody responses, hematological parameters, and sarcocyst 
load in muscle tissue were identified between the two breeds. The pigs from the Pietrain 
breed were consistently more severely affected and demonstrated a sarcocyst load up to 
eighty times that of the Meishan in muscle tissue. This preliminary study provides evidence 
of large enough genetic differences between pigs of these two breeds to pursue breed crosses 
and future QTL analysis of susceptibility to a protozoan parasite. 
What justifies a pathogen as a good candidate for the financial investment required to 
investigate genetic susceptibility? Socioeconomic impact, welfare and comfort of the 
livestock host, availability of effective prophylactic and/or treatment measures (or lack 
thereof), ability to control spread through private and government restrictions, and a public 
perception of overuse of antimicrobials in food animal species have each increased the 
desirability of identifying the genetic factors underlying susceptibility to infectious diseases. 
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What are the general requirements for the multiple strategies that can be used to identify and 
analyze the genetic control of diseases (Adams and Templeton, 1998)? First, variation in the 
host response to the pathogen must exist. Second, the experimental design must provide 
relatively constant environmental conditions since variability in expression of disease traits 
has some portion that is due to environmental interaction. Third, a standard disease model 
and challenge dose must be established prior to the susceptibility study, preferably one which 
mimics the natural route of infection. Fourth, a constant state of virulence of the pathogen is 
necessary for reproducing the clinical and pathological parameters of the disease. Finally, 
consistent and objective methods for measuring the disease traits must be established and 
utilized in the subsequent susceptibility studies. 
Porcine reproductive and respiratory syndrome virus 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped 
positive-strand RNA virus in the family Arteriviridae first identified in the U.S. and the 
Netherlands. The abortion and respiratory disease syndrome associated with this newly 
emerged pathogen was described in the late 1980s and the causative agent was isolated in the 
early 1990s (Benfield et al., 1992; Collins et al., 1992). The PRRSV genome is 
approximately 15 Kb in length and is composed of eight open reading frames (ORF) 
(Meulenberg, 2000). The nonstructural proteins that comprise the RNA replicase and 
associated enzymes are encoded in ORFs la and lb. The three major structural proteins, the 
glycoprotein 5 (GP5), matrix, and nucleocapsid proteins, are encoded by ORF 5, 6, and 7, 
respectively. The remaining ORFs encode for minor structural proteins. Of the viral 
proteins, the nucleocapsid protein is expressed in the highest numbers in infected cells and is 
immunodominant, however antibodies produced against this viral protein are not neutralizing 
and do not prevent infection (Meulenberg et al., 1998). Neutralizing antibodies are produced 
against GP4 and GP5 and the principle neutralizing epitope has been identified in the 
ectodomain of the GP5 protein (Weiland et al., 1999; Ostrowski et al., 2002; Plagemann et 
al., 2002). As in most RNA viruses, variation in the genomic sequence exists between 
isolates, and ORF 5 has been found to be the most variable structural protein (Murtaugh et 
al., 1998). This is not an unexpected finding due to the ability of neutralizing antibodies 
against this protein to reduce or prevent infection. 
The PRRS virus is responsible for financial losses due to both respiratory and 
reproductive disease in pigs and is estimated to cost producers from $6.00 to $15.00 per 
market weight animal (Hoick and Poison, 2003). The virus can be enzootic in some herds 
with relatively minimal impact while other herds exhibit periodic epizootics with dramatic 
effects on production (Blaha, 2000). In growing pigs, PRRSV causes an interstitial 
pneumonia with mononuclear infiltrates in the septa and alveoli, resulting in fever, lethargy, 
anorexia, and respiratory distress (Collins et al., 1992). An experimental model of 
respiratory disease has been established through intranasal challenge with high virulence, low 
passage PRRSV (Halbur et al., 1995). The PRRS virus preferentially infects resident 
macrophages of various tissues, primarily pulmonary alveolar macrophages (PAM) and 
pulmonary intravascular macrophages (PIM) in the respiratory form of the disease. Primary 
cultures of PAMs and monocyte derived macrophages (MDMs) can be infected in vitro, and 
positive cells detected through fluorescence-activated cell sorting (FACS) (Thacker et al., 
1998). The porcine sialoadhesin has been identified as a receptor for PRRSV on the surface 
of macrophages, and the virus enters through pH-dependent receptor-mediated endocytosis 
(Kreutz and Ackermann, 1996; Vanderheijden et al., 2003). The PRRS virus decreases the 
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bactericidal activity of both PAMs and PIMs in the lung, although phagocytosis was 
unaltered (Thanawongnuwech et al., 1997; Thanawongnuwech et al., 1998). In addition, 
PRRSV infection in PAMS induces apoptosis in uninfected bystander macrophages 
(Sirinarumitr et al., 1998). The alteration and reduction in PAMs in the lung would suggest 
that PRRSV infection predisposes the host to secondary bacterial infections. This 
predisposition is indicated from field reports and post mortem findings, although a direct 
effect has been difficult to reproduce experimentally. The PRRS virus is commonly isolated 
from cases of porcine respiratory disease complex (PRDC) in association with other 
respiratory pathogens (Thacker, 2001). 
Although not classically immunosuppressive, it has become clear from the research 
reported over the last ten years that PRRSV manipulates the immune system via its effect on 
macrophages. The PRRS virus does not stimulate an early IFN-a response as would be 
expected in viral infections and its presence may be able to prevent the effective IFN-a 
response normally seen with other respiratory viruses such as porcine respiratory coronavirus 
when present in combination with PRRSV (Albina et al., 1998; Buddaert et al., 1998). 
However, addition of recombinant IFN-a has been shown to inhibit viral replication in vitro, 
suggesting the modulation of the type I interferons is an immune evasion strategy employed 
by PRRSV. The proinflammatory response is further modulated by PRRSV by the inhibition 
of tumor necrosis factor a (TNF-a) production (Van Reeth et al., 1999; Lopez-Fuertes et al., 
2000), while interleukin 1 (IL-1), a chemoattractant for monocytes, was still produced. 
Using differential display technology, the MX1 gene transcript was shown to be upregulated 
in macrophages infected with PRRSV (Zhang et al., 1999). The Mxl protein has been shown 
to be an important antiviral protein involved in the response by the innate immune system for 
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orthomyxoviruses (influenza virus) and rhabdoviruses in mice, but its role in pigs and 
PRRSV is unknown. 
Primary anti-PRRSV IgG serum antibodies are typically produced by 14 days post­
exposure, however neutralizing antibodies do not appear in the majority of pigs until greater 
than 3 to 4 weeks post-infection (Nelson et al., 1994; Loemba et al., 1996). The half-life of 
the antibodies produced varies extensively, and virus can persist and be detected in the face 
of antibodies from the time of their appearance until greater than 120 days post-infection 
(Horter et al., 2002; Wills et al., 2003). The ineffective humoral response appears to be, at 
least in part, the result of a polyclonal activation of B cells that is associated with persistency 
and a failure to clear the virus (Vezina et al., 1996; Lamontagne et al., 2001). In addition to 
the polyclonal nature of the response against PRRSV, an enhanced antibody response to 
other antigens has been demonstrated in pigs infected with PRRSV, and the increased 
antibody levels were not correlated with protection (Molitor et al., 1997; Thacker et al., 
2000). There is also evidence for antibody dependent enhancement of infection with low 
titers of neutralizing antibodies or maternal antibodies due to increased uptake of the virus by 
susceptible macrophages through the Fc receptor (Yoon et al., 1996; Murtaugh et al., 2002). 
The cellular immune response also appears to be modulated by PRRSV. In the lung, 
an increase in mononuclear cells has been demonstrated in response to infection. A portion 
of this influx was demonstrated to be CD8+ T cells, classified as CTLs by their staining 
pattern in flow cytometry in the acute stage of disease (Samsom et al., 2000). The expression 
of IFN-7 mRNA has also been shown to be upregulated in the lung and associated lymph 
nodes of ten day old piglets infected in utero (Bautista and Molitor, 1999; Rowland et al., 
2001). In addition, relatively high levels of IFN-7 were detected in BAL fluid by ELIS A at 
ten days post-infection with a high virulence isolate of PRRSV (Thanawongnuwech and 
Thacker, 2003), and an increase in IFN-7 was detectable by immunohistochemistry in lung 
tissue at the same time point (Thanawongnuwech et al., 2003). In contrast, the number of 
inducible IFN-7-producing T cells in the peripheral blood mononuclear cell (PBMC) 
population was shown to be much lower than that of other viral infections and was slow to 
rise (Meier et al., 2003). The response was not detectable until three weeks post infection, 
appearing at approximately the same time as neutralizing antibodies. The T cell populations 
in PBMCs responsible for the eventual IFN-7 production were shown to be primarily 
CD4+CD8+ double-positive memory T cells with a minor CD8+ population. Although there 
are conflicting reports in the literature regarding the kinetics and quantity of IFN-7 
production, it seems apparent that the cellular response to PRRSV is ineffective in rapid 
clearance of the virus. The delayed IFN-7 response may be due to an evasion mechanism of 
PRRSV since recombinant IFN-7 has been shown to reduce or prevent PRRSV replication in 
both macrophages and the permissive MARC-145 cell line in vitro, and the slow appearance 
of IFN-7 is likely associated with the eventual clearance of the virus (Bautista and Molitor, 
1999; Rowland et al., 2001). 
The contradiction between the presence of detectable IFN-7 in the lung and the lack 
of viral clearance may be the result of counteracting cytokine responses in the lung. 
Interleukin-10 is a cytokine produced by macrophages and Th cells that acts to downregulate 
macrophage activation, decrease the differentiation of T lymphocytes into the TrI 
phenotype, and prevent apoptosis, all of which would presumably decrease the efficacy of 
the immune system in eliminating a viral pathogen such as PRRSV that infects macrophages. 
Various other intracellular pathogens have been shown to either produce an IL-10 homolog 
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or induce IL-10 production by the host to modulate the immune system (Redpath et al, 
2001). Interleukin-10 mRNA transcripts have been shown to be upregulated in response to 
PRRSV in cells isolated from BAL (Suradhat and Thanawongnuwech, 2003; 
Thanawongnuwech and Thacker, 2003) and from peripheral blood (Suradhat et al., 2003). In 
addition, the presence of PRRSV prevented a typical IFN-7 recall response in vitro to 
classical swine fever virus in conjunction with the increased IL-10 (Suradhat et al., 2003). 
These reports indicate that the induction of IL-10 may be one mechanism responsible for 
enabling the PRRSV to evade the immune system by shifting the balance from a productive 
neutralizing antibody, IFN-7 response to a less effective polyclonal antibody, anti­
inflammatory response. 
Just as the immune response to PRRSV on an individual level is complex, the 
response to this virus within and between populations is just as complicated. Varying levels 
of disease induced by a single strain of PRRSV between pigs of the same population have 
been observed in naturally and experimentally infected animals (Halbur et al., 1998), as well 
as with macrophages infected in vitro (Voicu et al., 1994; Molitor et al., 1996). Reports in 
the literature on differences in susceptibility to PRRSV have been limited, although 
anecdotal reports from field observations suggest wide ranges in clinical disease within and 
between farms that may be attributed in part to genetic differences in the pigs. An 
experimental challenge study using pigs from Duroc, Hampshire, and Meishan breeds 
demonstrated differences in PRRSV pathology between breeds, most notably that Hampshire 
pigs had significantly higher PRRSV-induced macroscopic lung lesions (Halbur et al., 1998). 
In another study, additive genetic variation in susceptibility to respiratory diseases was 
detected in pigs from Yorkshire, Duroc, Landrace, and Hampshire breeds, with Duroc and 
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Yorkshire breeds showing an increase in general resistance to clinical and subclinical 
respiratory disease (Henryon et al., 2001). However, the characterization of the respiratory 
disease and inciting pathogen were not individually evaluated. Each of these studies 
investigated differences between purebred animals, while no evidence has been presented for 
differences in commercial crossbred lines commonly used in swine operations around the 
world. 
Identification of lines with decreased susceptibility to PRRSV-induced disease would 
be of great value to the swine industry due to the economic impact of PRRSV and the 
difficulty in managing the disease through traditional methods that include vaccination and 
biosecurity measures (Opriessnig et al., 2002; Verheije et al., 2003). The 
immunomodulatory properties of PRRSV and the difficulty in producing safe modified live 
vaccines have stalled effective vaccine production. Highly virulent strains of PRRSV can 
cause extreme losses due to both reduced reproductive performance in adult animals and 
impaired growth and increased mortality in growing animals. In addition to an inefficient 
host response to PRRSV alone, PRRSV has also been demonstrated to have an 
immunomodulatory effect on protection against other pathogens through reduced vaccine 
efficacy to M. hyopneumoniae and swine influenza virus (Thacker et al., 2000; Thacker et al., 
2003). Accordingly, low virulence strains may also cause economic losses due to impaired 
immune responses to concurrent or subsequent infections with other pathogens. 
If evidence of genetic control of susceptibility to PRRSV could be identified, the 
potential for selection of pigs that possess increased resistance to this economically important 
disease could be considered (Stear et al., 2001; van der Waaij et al., 2002). Genetic 
improvement would be further advanced by identification of individual genes or genetic 
markers related to resistance to PRRSV. Monoclonal antibodies have been utilized to 
identify and characterize the porcine sialoadhesin molecule as a receptor for PRRSV entry 
into tissue macrophages (Vanderheijden et al., 2003). Although transfection of the 
sialoadhesin gene alone was not sufficient for viral replication, the characterization of this 
gene may lead to potential sources of genetic variation in susceptibility to PRRSV. Immune 
responses through regulation of cell surface molecules, including the MHC and cytokine 
receptors, cytokines and chemokine production, activation of T lymphocyte subsets, and 
production of neutralizing antibodies are other potential mechanisms in which genetic 
selection could be utilized to improve the health status of swine by increasing the efficiency 
of the response against this important pig pathogen (Warner et al., 1987; Gogolin-Ewens et 
al., 1990; Edfors-Lilja et al., 1998). 
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CHAPTER 2. INVESTIGATION OF SUSCEPTIBILITY TO PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
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VITRO FLOW CYTOMETRIC ASSAY 
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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped RNA 
virus that is responsible for large financial losses in the swine industry worldwide. Control 
and prevention of PRRSV through traditional methods such as vaccination and biosecurity 
has proven to be difficult. It remains undetermined whether genetic variability in 
susceptibility to PRRSV exists and if this variability can be exploited to help control this 
important disease. The objective of this study was to determine if an in vitro PRRSV flow 
cytometry (FACS) assay designed to detect the percentage of PRRSV-infected monocyte-
derived macrophages (MDMs) could be utilized to detect genetic variability in the 
susceptibility of pigs to PRRSV infection and/or severity of respiratory disease. Over 400 
six-to-ten week old pigs, from six genetically distinct lines maintained in a single commercial 
breeding herd were screened using an in vitro FACS assay. From this initial screening, two 
genetically diverse lines of pigs that were also divergent in their FACS results were selected 
for further study, with Line A having a higher average percentage of infected MDMs in the 
FACS assay compared to Line B. An additional 264 pigs from these two lines were 
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subsequently tested for in vitro susceptibility to PRRSV in four replicates. As in the 
preliminary screening, Line A had a significantly higher average percent positive MDMs in 
the FACS assay over Line B. This report provides evidence that the in vitro assay may be 
useful in predicting the relative susceptibility to PRRSV in large groups of animals. More 
importantly, these results provide evidence that there is a genetic component to the 
susceptibility to PRRSV and intensifies the need to fully understand the mode of infection 
and host response to this virus to define the underlying genetic factors in the pig. 
Keywords 
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Abbreviations: ANOVA, analysis of variance; FACS, fluorescence-activated cell sorting 
(flow cytometry); GM-CSF, granulocyte monocyte-colony stimulating factor; MDM, 
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1. Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped RNA 
virus in the genus Arterivirus in the order Nidovirales and is the agent responsible for 
extensive financial losses due to both respiratory and reproductive disease in pigs (Benfield 
et al., 1992). In growing pigs, PRRSV causes an interstitial pneumonia (Collins et al., 1992) 
that results in fever, lethargy, and respiratory distress. Respiratory disease has been 
experimentally reproduced through intranasal challenge with high virulence, low passage 
PRRSV (Halbur et al., 1995). PRRSV preferentially infects resident macrophages of various 
tissues, including pulmonary alveolar macrophages (PAM). Primary cultures of PAMs and 
monocyte derived macrophages (MDMs) can be infected in vitro, and positive cells detected 
through flow cytometry (FACS) (Thacker et al., 1998). If MDM susceptibility to the virus in 
vitro and PAM susceptibility in vivo can be correlated, this technique may be useful in 
identifying pigs that are more susceptible to the respiratory disease induced by PRRSV. 
Differences in virulence between isolates of PRRSV has been demonstrated 
experimentally (Halbur et al., 1996), but the differences may not fully explain the variation in 
disease severity observed under field conditions. Varying levels of susceptibility to a single 
strain of PRRSV among pigs in the same population have been observed in naturally and 
experimentally infected animals (Halbur et al., 1998), as well as with macrophages infected 
in vitro (Molitor et al., 1996; Voicu et al., 1994). If a genetic mode of susceptibility to 
PRRSV can be identified, there is potential for selection of pigs that possess increased 
resistance to this economically important disease. Genetic improvement would be further 
advanced by identification of genes or genetic markers related to resistance to PRRSV. 
Although the complete mechanism for each step of the lifecycle of PRRSV has not been 
identified, monoclonal antibodies against cell surface antigens on PAMs block infection in 
vitro (Duan et al., 1998; Nauwynck et al., 1999). More recently, one of these monoclonal 
antibodies has been utilized to identify and characterize the porcine sialoadhesin molecule as 
the receptor for PRRSV entry into tissue macrophages (Vanderheijden et al., 2003). 
Although transaction of the sialoadhesin gene alone was not sufficient for viral replication, 
the characterization of this gene may lead to potential sources of genetic variation in 
susceptibility to PRRSV. In addition to viral receptor(s), host responses including regulation 
of expression of cell surface molecules, such as the major histocompatibility complex (MHC) 
proteins and cytokine or chemokine receptors, cytokine production, and antibody production 
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are other potential mechanisms by which genetic selection could be utilized to improve the 
health status of swine (Edfors-Lilja et al., 1998; Gogolin-Ewens et al., 1990; Warner et al., 
1987). 
The purpose of this investigation was to identify possible differences in susceptibility 
to PRRSV between six genetically diverse lines of pigs. The primary objective of this study 
was to determine if an in vitro PRRSV FACS assay could be utilized to detect the existence 
of genetic variability in the susceptibility of the host to PRRSV infection. From the results of 
the six screened lines, two genetically distinct lines with divergent FACS results were 
selected for further study to confirm the results of the preliminary screening. 
2. Materials and Methods 
2.1 Experimental Design 
This study was conducted in two parts. The preliminary investigation evaluated flow 
cytometric results from six genetic lines that were maintained at the farm site. Results from 
this phase were utilized to select the two highly divergent lines included in the subsequent 
study. The second phase of the study was conducted at Iowa State University using animals 
procured from the original source farm. 
2.2 Blood collection and isolation ofPBMC 
The first phase of the experiment was conducted over a 5-month period. A volume of 
20 ml of blood was collected by venapuncture into heparinized tubes from each of 419 6- to 
10-week-old pigs from 6 genetic lines originating from Large White, Landrace, Duroc, 
Hampshire, and Pietrain breeds. All animals were from a single PRRSV-free commercial 
breeding herd. The blood was shipped overnight at ambient temperatures and processed 
immediately upon arrival as described below. The follow-up investigation of the two selected 
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lines was conducted in four independent replicates. In each of the replicates, blood was 
collected from 4-to-6 week old pigs by venapuncture into heparinized tubes and processed 
the same day. The first replicate contained 38 animals per line and the following 3 replicates 
contained approximately 34 animals per line. The study was conducted in accordance with 
the guidelines of the Iowa State University Institutional Committee on Animal Care and Use. 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood and 
transformed into macrophages using an established protocol with some modification 
(Genovesi et al., 1989). The cells were isolated with Histopaque 1077 (Sigma, St. Louis, 
MO) and resuspended in complete media (RPMI-1640, 10% FBS, 100 U/ml penicillin G, 100 
Hg/ml streptinomycin, and 50 jag/ml gentamicin). The PBMCs were plated onto 6-well tissue 
culture plates with two wells per animal and incubated overnight at 37° C with 5% CO2. The 
following day, non-adherent cells were gently washed away and removed. Fresh complete 
media along with L929 supernatant containing granulocyte-monocyte colony stimulating 
factor (GM-CSF) was added to transform the adherent PBMCs to MDMs. After 24 hours, 
PRRSV was added to the media at a multiplicity of infection (MOI) of 1 and allowed to 
incubate for another 24 hours. Negative controls containing non-infected MDMs were 
included for each animal. 
2.3 Flow cytometry 
The percentage of PRRSV infected MDMs was detected using a previously described 
method (Thacker et al., 1998). Briefly, cells were collected into phosphate-buffered saline 
with 1% bovine serum albumin and 0.1% sodium azide (FACS Buffer) using a rubber 
scraper and plated on 96-well U-bottom plates. MDMs were labeled using an SWC3 
antibody (74-22-15, VMRD, Pullman, WA) that recognizes monocytes and macrophages, 
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followed with a goat anti-mouse IgG (whole molecule) conjugated with R-phycoerythrin 
(PE) (Southern Biotechnology Associates, Inc., Birmingham, AL). The cells were fixed with 
4% formaldehyde and then made permeable with FACS Buffer plus 0.1% saponin (FACS-S 
Buffer). The intracellular nucleocapsid protein of PRRSV was labeled with the monoclonal 
antibody SDOW-17 (Rural Technologies, Brookings, SD), followed with a goat anti-mouse 
IgGl conjugated with fluorescein isothiocyanate (FITC) (Southern Biotechnology 
Associates, Inc., Birmingham, AL) in FACS buffer with saponin. The percent of PE-positive 
cells that were dual labeled with FITC were identified by flow cytometry based on 10,000 
events. The cell populations in the infected wells were gated on the corresponding uninfected 
SWC3-PE positive population for each animal. 
2.4 PRRSV RNA quantitation with real time RT-PCR 
After the MDMs were loosened with the rubber scraper in 0.5 ml of FACS Buffer, a 
140 jul aliquot was removed for the 69 samples in replicate 3 and stored at -80°C. The 
quantity of PRRSV RNA in the MDMs isolated for flow cytometry was determined using 
real time reverse transcriptase-polymerase chain reaction (RT-PCR) (A. Vincent, 2003, 
submitted). Viral RNA was extracted from each aliquot of MDMs following a freeze-thaw 
step for lysis using a commercial kit (QIAamp viral RNA Mini Kit, Qiagen Inc., Valencia, 
CA) according to the manufacturer's recommendations. Each RNA sample was eluted in 60 
(0.1 of the provided elutant and stored at -20 °C until used. A FAM-labeled LUX fluorogenic 
forward primer (Invitrogen Corp., Carlsbad, CA) (5'-
cactcc AG AA AAGCT GTT A A AC AGGG AGT G-3 ' ) with the additional nonspecific 
nucleotides added to the 5 ' end to form the hairpin in lower case letters and the thymidine 
labeled with F AM in bold, was used for real time detection. The LUX forward primer and 
corresponding unlabeled reverse primer (5 ' -TCTGCTGCTTGCCGTTGTTA-3 ') were used 
to produce a 74 bp product within the PRRSV ORF 6 and ORF 7. A 405nt cRNA standard 
was used as the external RNA standard in a real time quantitative RT-PCR assay. The cRNA 
standard was serially diluted by ten-fold copy number, and concentrations of 106 to 109 
copies/pi were run in duplicate in the real time RT-PCR assay to produce an external 
standard curve for each run. 
One-tube RT-PCR was performed in duplicate for each MDM RNA sample in 
replicate 3 using the Brilliant® single-step QRT-PCR system (Stratagene, La Jolla, CA) with 
the following conditions in a 25 /xl reaction: IX buffer, 2.5mM magnesium chloride, 0.8 juM 
dNTP mix, 0.3 jiM each primer, 0.02 U StrataScript™ reverse transcriptase, 0.05 U 
SureStart® Taq polymerase, and 2 pd RNA template. The RT-PCR program consisted of 45 
°C for 30 min, 95 °C for 10 min, and 40 cycles of 95 °C for 15 sec, 63 °C for 30 sec, and 72 
°C for 30 sec. Acquisition of fluorescence was done after each cycle. Following the final 
cycle, a melting curve was generated. The reactions were carried out in a Rotor-Gene 4.6 real 
time thermal cycler system (Corbett Research, Mortlake, NSW, Australia). For each run, a 
standard curve with the beginning cRNA copy number/pl plotted against the threshold cycle 
number (C?) was generated using ten-fold serial dilutions by copy number of the 405 nt 
cRNA standard run in duplicate. The external standard curve was used to calculate the 
starting template concentration of the test samples. The calculated concentrations for the 
duplicate samples were averaged to give the copy number per [il of the ORF 6/7 transcript in 
the sample when the difference between the two samples was less than 0.5 log unit. If the 
difference exceeded this limit, the results were considered questionable and the sample was 
re-tested. 
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2.5 Statistical Analysis 
Data from the initial FACS screening and subsequent FACS testing were analyzed 
using analysis of variance (ANOVA). Three-hundred-ninety-eight animals from the FACS 
screening were analyzed using a model that included line, sire, sex, and date bled, with 
percent of positive cells in the FACS assay as the dependent variable. For data generated 
from the subsequent FACS analysis, line, trial replicate and sex were assumed to be fixed 
effects, sire was assumed to be a random effect, and FACS result was the dependent variable 
included in the model. Two-hundred-sixty-four data points were included in the analysis. The 
real time RT-PCR and FACS results were analyzed using ANOVA using a model including 
line and sire within line, and linear regression was used to calculate the correlation between 
real time RT-PCR and FACS results. 
3. Results 
3.1 FACS Screening 
The FACS results from 398 animals from 5 lines are summarized in Table 1. Results 
for 21 animals in the 6th line were omitted from the analysis due to the low number of 
animals available for testing. Genetic line was shown to have a significant effect (p < 0.05). 
From these results, lines A and B were chosen for the subsequent study due to their genetic 
divergence and the large difference between the LS mean FACS results between these 2 
lines. 
3.2 FACS Assay for the two selected lines 
The difference between Lines A and B within the individual replicate means was only 
significant in replicate 3 (Figure 1). However, over the 4 trial replicates the difference 
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TABLE 1. Least squares means of percentage of PRRSV positive cells by line from 
preliminary FACS screening.3 
Line No. Pigs Mean ± SEM 
A 81 28.9 ± 2.0" 
B 88 14.2 ± 1.2b 
C 60 22.7 ±2.1° 
D 75 19.1 ± 1.9C 
E 94 17.8 ± 1.5a'c 
aMeans reported as percent of PE labeled cells dual labeled with FITC. Means with differing 
superscripts significantly different at p < 0.05. 
between the means was significant, with line A having an average of 31.8 percent positive 
MDMs and Line B an average of 23.0 positive cells (p < 0.02). Trial replicate was shown to 
have a significant effect and was thus included in the statistical model. This effect is most 
likely due to the inherent variations that exist in biologic assays, and although the magnitude 
of the level of positive MDMs varied from replicate to replicate, the relationship between the 
two lines remained consistent (Figure 1). 
3.3 PRRSV RNA quantitation with real time RT-PCR 
The least square mean in copy number per ju.1 of PRRSV ORF 6/7 RNA was 
significantly different between the two lines, with Line A averaging 108 0 and Line B 
averaging 107'6 (p < 0.01) (Figure 2). The real time quantitative RT-PCR results were 
significantly correlated with the percentage of positive MDMs in the FACS assay with an R2 
of 0.48 (p < 0.0001), indicating that at the 24 hour time point in vitro, the number of infected 
MDMs is positively correlated to the amount of ORF 6/7 viral RNA. 
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Figure 1. Least squares means for percentage PRRSV positive MDM in the FACS assay in 
each of the four replicates and overall. Although the trial replicate had a significant effect and 
the magnitude of positives varied in each replicate, the relationship between the two lines 
remained consistent with Line A (black bar) having a higher mean percentage infected MDM 
over Line B (gray bar). *The differences between the two lines in overall LS means was 
significant at p<0.01. 
7.8 S O 
MEAN FACS Log 10 MEAN RT 
Figure 2. Least squares means for percentage of PRRSV positive MDMs in the FACS assay 
in replicate 3 compared with LS means for copy number of PRRSV ORF 6/7 RNA in MDMs 
by genetic line. The LS means for percent positive MDM were 45.9 for Line A (black bar) 
and 24.4 for Line B (gray bar) (p < 0.0001). The LS means for copy number of PRRSV ORF 
6/7 RNA was 108'° for Line A and 107'6 for Line B (p < 0.01). RT-PCR was positively 
correlated with FACS results with an R2 of 0.48 (p < 0.0001). 
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4. Discussion 
In this experiment, we utilized an in vitro PRRSV MDM FACS assay (Thacker et al., 
1998) to identify differences in susceptibility to PRRSV between genetic lines, with the 
ultimate goal of using the assay as an indicator trait for overall susceptibility in vivo. 
Significant differences between the mean FACS results within distinct genetic lines of pigs 
were observed. Reports in the literature on differences in susceptibility to PRRSV have been 
limited, although anecdotal reports from field observations suggest wide ranges in clinical 
disease within and between farms that could be attributed to genetic differences. A study 
using Duroc, Hampshire, and Meishan breeds demonstrated differences in PRRSV-induced 
pathology between breeds, most notably that Hampshire pigs had significantly higher 
percentages of PRRSV-induced macroscopic lung lesions (Halbur et al., 1998). In another 
study, additive genetic variation in susceptibility to respiratory diseases as a category was 
detected in Yorkshire, Duroc, Landrace, and Hampshire breeds, with Duroc and Yorkshire 
breeds showing an increased general resistance to clinical and subclinical respiratory disease 
(Henryon et al., 2001). However, the study did not determine the type of respiratory disease 
or inciting pathogen individually. Each of these studies investigated differences between pure 
bred animals. No evidence has been presented for differences in commercial cross-bred lines 
of pigs that are commonly used in commercial production facilities around the world. 
Based on the in vitro assay described here, variability in susceptibility of 
macrophages to PRRSV between genetic lines exists and further investigation is warranted to 
evaluate the in vivo differences between these and other genetically distinct populations. It 
should be noted that the flow cytometry assay is done at one time point, 24 hours post 
infection. The percentage of positively stained infected cells was directly correlated with the 
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amount of viral RNA in the MDMs, suggesting that the difference between the two lines is in 
permissiveness to viral entry and there is no difference in replication efficiency between the 
two lines at the 24 hour time point in vitro. The 24 hour time point was chosen for the in 
vitro FACS assay due to the limited number of MDMs produced from peripheral monocytes 
and the induction of apoptosis in PRRSV infected cultures that occurs 24 hours post infection 
(Sirinarumitr et al., 1998). 
It has been shown that PRRSV has a restricted tropism for some populations of 
macrophages and different stages of activation can influence their susceptibility to the virus 
(Duan et al., 1997). Since the macrophage is a potent effector cell of the immune response, it 
is not clear how many of the infected macrophages in vivo would support propagation of 
virus and/or would stimulate an immune response through autocrine or paracrine activation. 
Studies investigating the pathways for PRRSV infection have shown that virus attachment 
occurred in nearly all alveolar macrophages cultured with virus within 60 minutes, however, 
viral replication only appeared to occur in 30% of the cells (Nauwynck et al., 1999). In 
addition, PRRSV has been shown to induce apoptosis primarily in noninfected bystander 
macrophages in vivo and in vitro (Labarque et al., 2003; Sirinarumitr et al., 1998), which may 
be a protective mechanism by the host to prevent subsequent infection of migrating 
monocytes by infected resident macrophages. 
PRRSV has been shown to use surface sialoadhesin on macrophages for virus entry 
through clathrin mediated endocytosis. However, the presence of this gene alone was 
insufficient to support uncoating and replication in transacted cells (Vanderheijden et al., 
2003), indicating additional steps are required in the infectious pathway. All of these factors 
suggest that host resistance to PRRSV is complex and a more complete understanding of the 
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molecular pathogenesis of PRRSV may reveal the biologic basis for the relationship between 
the in vitro FACS assay and PRRS disease traits. 
Variation in the assay between replicates is of concern. This variation is most likely 
due to the inherent inconsistencies that are characteristic of biologic assays. To remove assay 
to assay variation, it would be beneficial to incorporate an index macrophage cell line to 
control for changes in culture conditions and inactivity of the virus in vitro. However, to 
date, continuous macrophage lines have not been shown to support PRRSV infection 
(Weingartl et al., 2002), and the mechanism of infection for the permissive MARC-145 cells 
has been shown be quite different than that of macrophages (Nauwynck et al., 1999) and 
therefore is not a suitable index cell line for the PRRSV FACS assay. 
Assay variation by an individual animal is also likely affected by immune status of 
the pig, age at testing, and unknown environmental factors. The health status of the animals 
used in this study changed between replicates, but no other alternative animals could be used 
due to the requirements of specific genetic lines and PRRSV-free status. Study animals were 
found to be infected with Bordetella bronchiseptica, Pasteurella multocida, Mycoplasma 
hyorhinis, and porcine coronavirus. Lesions suggestive of Mycoplasma hyopneumoniae and 
cytomegalovirus infections were also present, but the organisms were not isolated. In an 
attempt to reduce the impact of concurrent infections in the second phase of the study, the 
two lines were mixed as pen-mates in the same isolation room. 
Identification of lines with decreased susceptibility would be of great value to the 
swine industry since PRRS has a major economic impact and remains difficult to manage 
using traditional methods. Highly virulent strains of PRRSV can cause extreme losses due to 
both reduced reproductive performance in adult animals and loss of growth and increased 
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mortality in growing animals. In addition, PRRSV has been demonstrated to have an 
immunomodulatory effect and reduces the efficacy of M. hyopneumoniae and swine 
influenza virus vaccines (Thacker et al., 2003; Thacker et al., 2000). Accordingly, even low 
virulence strains may cause economic losses due to a reduction in efficient immune response 
against pathogens infecting pigs that should be protected by vaccination. Existence of lines 
with large differences in susceptibility may also allow for development of line crosses that 
would facilitate genomic scans to identify quantitative trait loci (QTL) associated with 
resistance to PRRSV. If chromosomal regions or specific genes exist for PRRSV 
susceptibility, there is the potential to develop genetic markers to further aid in the selection 
of animals with increased resistance (van der Waaij et al., 2002). Increasing our 
understanding of the pathogenesis of PRRSV and the molecules involved in regulating the 
specific immune responses that take place in the host will be beneficial in identifying specific 
genes that could be used to develop genetic markers that improve health traits of pigs. Such 
an understanding is also fundamental for improving preventative and therapeutic strategies 
for controlling this important swine pathogen. 
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Abstract 
The objective of this study was to determine if host genetics plays a role in 
susceptibility to the respiratory disease in growing pigs caused by the porcine reproductive 
and respiratory syndrome virus (PRRSV). Based on a previous study, two genetically diverse 
commercial lines of pigs that were also divergent in the susceptibility of monocyte derived 
macrophages to PRRSV infection in vitro (FACShl and FACS10 lines) were selected for an in 
vivo challenge study. Pigs from each line were challenged at 6 weeks of age with PRRSV 
VR-2385 and necropsied at 10 or 21 days post infection. Data collected included clinical 
evaluation of disease, virus titration in serum and lung lavage fluid, macroscopic lung lesion 
scores, and microscopic lung lesion scores. The FACS10 line had consistently more severe 
clinical disease compared to the FACShl line in the early stages of infection. Differences 
between line means were statistically significant at 10 days post infection for all data 
variables described above, and these variables were negatively correlated with the in vitro 
susceptibility results. By 21 days post infection, clinical signs and lesions were resolving and 
the differences between lines were statistically significant only for virus titer in serum. 
Interestingly, at 21 DPI the relationship between the lines reversed with the FACShl line 
having significantly higher serum titers. This report provides evidence that strongly suggests 
the existence of a host genetic component in disease susceptibility to PRRS, and indicates 
that further study is warranted to define the cellular mechanisms that affect disease 
susceptibility. 
INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped RNA 
virus in the family Arteriviridae and is responsible for financial losses due to both respiratory 
and reproductive disease in pigs (1). In growing pigs, PRRSV causes an interstitial 
pneumonia (3) resulting in fever, lethargy, and respiratory distress. Respiratory disease has 
been experimentally reproduced through intranasal challenge with high virulence, low 
passage PRRSV (8). The PRRS virus preferentially infects resident macrophages of various 
tissues, including pulmonary alveolar macrophages (PAM) and pulmonary intravascular 
macrophages. Primary cultures of PAMs and monocyte derived macrophages (MDMs) can 
be infected in vitro, and positive cells detected through fluorescence-activated cell sorting 
(FACS) (21). A flow cytometric assay that detects the percentage of PRRSV infected MDMs 
in vitro has been utilized to demonstrate the presence of variation in cell infection levels 
between genetic lines of pigs, leading to the characterization of FACShl and FACS10 lines 
based on the average percentage of infected MDMs by line (A. L. Vincent, B. J. Thacker, P. 
G. Halbur, M. F. Rothschild, and E. L. Thacker, submitted for publication). However, 
association with disease parameters in vivo had not been assessed. 
Varying levels of disease induced by a single strain of PRRSV between pigs of the 
same population have been observed in naturally and experimentally infected animals (10), 
as well as with macrophages infected in vitro (16, 25). Reports in the literature on differences 
in susceptibility to PRRSV have been limited, although anecdotal reports from field 
observations suggest wide ranges in clinical disease within and between farms that may be 
attributed in part to genetic differences in the pigs. An experimental challenge study using 
pigs from Duroc, Hampshire, and Meishan breeds demonstrated differences in PRRSV 
pathology between breeds, most notably that Hampshire pigs had significantly higher 
PRRSV-induced macroscopic lung lesions (10). In another study, additive genetic variation 
in susceptibility to respiratory diseases was detected in pigs from Yorkshire, Duroc, 
Landrace, and Hampshire breeds, with Yorkshire and Duroc breeds showing an increase in 
general resistance to clinical and subclinical respiratory disease (11). However, the 
characterization of the respiratory disease and inciting pathogen were not individually 
evaluated. Each of these studies investigated differences between purebred animals while no 
evidence has been presented for differences in commercial crossbred lines commonly used in 
swine operations around the world. 
If evidence of genetic control of susceptibility to PRRSV could be identified, the 
potential for selection of pigs that possess increased resistance to this economically important 
disease could be considered (20, 23). Genetic improvement would be further advanced by 
identification of individual genes or genetic markers related to resistance to PRRSV. 
Monoclonal antibodies have been utilized to identify and characterize the porcine 
sialoadhesin molecule as a receptor for PRRSV entry into tissue macrophages (24). Although 
transaction of the sialoadhesin gene alone was not sufficient for viral replication, the 
characterization of this gene may lead to potential sources of genetic variation in 
susceptibility to PRRSV. In addition to surface receptors for the virus, molecules involved in 
the host innate and/or adaptive response to PRRSV are other potential targets for 
investigating genetic susceptibility. 
The purpose of this investigation was to identify differences in vivo between two 
genetically diverse lines of pigs that had been identified as FACShl or FACS10, Line A and 
Line B, respectively, from previous study using an in vitro PRRSV-MDM FACS assay (A. L. 
Vincent, B. J. Thacker, P. G. Halbur, M. F. Rothschild, and E. L. Thacker, submitted for 
publication). The average percentage of PRRSV infected MDMs was shown to differ 
statistically between the two lines, indicating the susceptibility to the virus of the 
macrophages in culture varied. To investigate these differences in vivo, PRRSV challenge 
studies were conducted in four independent replicates. Pigs were experimentally infected and 
evaluated for disease susceptibility using the FACS assay, clinical presentation, macroscopic 
lesions, microscopic lesions, and virus titers in serum and lung lavage fluid. The study 
reported here provides evidence for a genetic basis in susceptibility to PRRSV-induced 
infection and disease that is correlated with the PRRSV-infected MDM in vitro FACS assay. 
MATERIALS AND METHODS 
Animals. Two-hundred and sixty-four animals, 2 to 4 weeks of age, from the FACS1" and 
FACS10 lines were procured from the same PRRSV-free source farm in four independent 
replicates. The group representing FACS1" (Line A) contained offspring from 11 sires and 29 
litters. The group representing FACS10 (Line B) contained offspring from 11 sires and 33 
litters. Each pig was treated daily by intramuscular injection with lincomycin hydrochloride 
(Lincocin, Pharmacia & Upjohn, Kalamazoo, MI) and ceftiofur hydrochloride (Excenel, 
Pharmacia & Upjohn, Kalamazoo, MI) for 3 days after arrival. The initial replicate contained 
30 animals per line in the challenge group, and pigs with the same sire were randomly sorted 
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into 6 pens of 10 pigs each. The following 3 replicates contained 24 animals per line in the 
challenge group, and pigs with the same sire were randomly sorted into 6 pens of 8 pigs each. 
Additional animals (n=60) used as experimental negative controls were housed in a separate 
isolation facility during each respective replicate. Pigs were infected intranasally at 
approximately six weeks of age (0 days post infection, DPI) and subsequently necropsied on 
10 or 21 DPI. The study was conducted in accordance with the guidelines of the Iowa State 
University Institutional Committee on Animal Care and Use. 
In vitro susceptibility of MDMs. The PRRSV-MDM FACS results reported previously were 
analyzed with the data generated in this study to investigate the relationship between the in 
vitro susceptibility to PRRSV and the in vivo disease variables described here with the in 
vitro assay results and in vivo parameters collected from the same groups of animals. Briefly, 
in each of the replicates, blood was collected from 4-to-6 week old pigs by venapuncture into 
heparinized tubes and processed the same day. Peripheral blood mononuclear cells (PBMCs) 
were isolated from the blood and the adherent monocytes were transformed into 
macrophages using an established protocol (6, 21). After 24 hours, PRRSV (VR-2385) was 
added to the media at a multiplicity of infection (MOI) of 1 and allowed to incubate for 
another 24 hours. Negative controls containing non-infected MDMs were included for each 
pig to standardize the FACS analysis. MDMs were labeled using an antibody (74-22-15, 
VMRD, Pullman, WA) that recognizes monocytes and macrophages, followed with a goat 
anti-mouse IgG (whole molecule) conjugated with R-phycoerythrin (PE) (Southern 
Biotechnology Associates, Inc., Birmingham, AL). The cells were fixed with 4% 
formaldehyde and then permeabilized with FACS buffer plus 0.1% saponin (FACS-S buffer). 
The intracellular nucleocapsid protein of PRRSV was labeled with the monoclonal antibody 
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SDOW-17 (Rural Technologies, Brookings, SD), followed with a goat anti-mouse IgGl 
conjugated with fluorescein isothiocyanate (FITC) (Southern Biotechnology Associates, Inc., 
Birmingham, AL) in FACS-S buffer. The percent of PE-positive MDMs that were dual 
labeled with FITC, representing the PRRSV infected macrophage population, were identified 
by flow cytometry based on 10,000 events. 
Blood Collection and Serology. Blood was collected from all pigs before and after 
challenge to monitor for the presence of PRRSV antibodies. Serum samples were tested 
using a commercially available enzyme-linked immunofluorescent assay (ELISA) 
(HerdChek: PRRS; IDEXX Laboratories, Westbrook, ME). Samples were also collected 
from all pigs at 10 DPI and from the remaining pigs at 21 DPI for use in virus titration and 
molecular quantification. 
Virus Inoculum and Challenge. The PRRSV inoculum was prepared as previously 
described (8,10). A high virulence, low passage strain was used (VR-2385) at a dosage of 
105 to 106 TCIDso/ml. The inoculum was administered by dripping 2.5 ml into each nostril of 
the animals in each of the challenge groups. Animals were challenged at approximately 6 
weeks of age, and this day was designated as 0 DPI. 
Clinical Evaluation. Animals were observed daily beginning on 0 DPI through 10 DPI for 
clinical signs of disease. Rectal temperatures were measured, and pigs were evaluated and 
assigned a score (0-6) for respiratory distress using a previously described method (9). From 
10 DPI to the final necropsy at 21 DPI, animals were evaluated every other day. 
Temperatures were converted to a temperature score by giving those pigs with normal 
temperatures a 0 (<104.0° F) and those with elevated temperatures a 1 ( ^04.0° F), indicating 
the number of days the animal was febrile. The scores were totaled for each time period, 0-10 
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DPI, 12-20 DPI, or 0-20 DPI. Respiratory scores were also totaled for each animal within 
each time period. 
Pathological Examination. At 10 DPI, approximately one-half of the pigs from each 
challenged line were necropsied, followed by the remaining half from each line at 21 DPI. 
The lungs were removed and evaluated for macroscopic lesions and samples collected for 
culture. Each lung lobe was given a score to reflect the percentage affected by pneumonia as 
previously described (8). The scores for the lobes were added to give a total lung score to 
indicate the percent of the total lung with grossly visible lesions. A bronchial swab was 
collected for each animal and cultured for swine respiratory pathogens, including Bordetella 
bronchiseptica, Pasteurella multocida, Actinobacillus spp, Haemophilus spp, and 
Mycoplasma hyorhinis. Samples were inoculated onto blood agar and streaked with a 
Staphylococcus epidermidis nurse colony for support of A. pleuropneumoniae and 
Haemophilus spp.. Isolated bacteria were identified according to standard methods. The 
lungs were then lavaged with 50 ml of minimal essential media (MEM) with antibiotics (100 
U/ml penicillin G, 100 p.g/ml streptinomycin, and 50 |ag/ml gentamicin) and bronchoalveolar 
lavage (BAL) fluid was collected. Tracheo-bronchial and middle iliac lymph nodes were 
removed and weighed. Tissue sections from all animals were taken from lung, lymph nodes, 
turbinate, brain, and heart, and then fixed in 10% neutral buffered formalin. Tissue sections 
were routinely processed, embedded in paraffin in an automated tissue processor, and stained 
with hematoxylin and eosin for histologic evaluation. Lung sections were blindly examined 
and given a score (0-6) based on the degree of interstitial pneumonia. 
Virus Titration and Quantification with QC-RT-PCR An aliquot of each serum or BAL 
sample from all 4 replicates was titrated in triplicate using a tissue culture method previously 
described (13, 15). The presence of PRRSV was detected using an indirect 
immunofluorescence assay with a monoclonal antibody against the nucleocapsid protein 
(SDOW-17, Rural Technologies, Brookings, SD) and a secondary goat anti-mouse IgG 
(whole molecule) conjugated with FITC (Sigma Aldrich Corp., St. Louis, MO). The TCID50 
was calculated using the Reed-Muench accumulative method (2). 
For replicates 2, 3, and 4, viral RNA was extracted from 140 jj.1 of sera or BAL using 
a commercial kit (QIAamp viral RNA Mini Kit, Qiagen Inc., Valencia, CA) according to the 
manufacturer's directions. Each RNA sample was eluted in 60 (j,l of the provided elutant. 
Quantitative competitive-reverse transcriptase-polymerase chain reactions (QC-RT-PCR) 
were run in triplicate for each test serum or BAL sample with three different concentrations 
of the 405 nucleotide competitor as previously described (A. Vincent and E. Thacker, Proc. 
32nd Amer. Assoc. of Swine Vet., 2001). Prior to running each set of samples, the range of 
competitor was established by testing a random selection of samples against a range of 
competitor concentrations from 106 to 1010 copy number per |_il. The reactions were run on 
2.5% agarose gels for approximately 1 hour. The gels were stained with ethidium bromide 
and the band intensities were analyzed using the digital imaging system GeneSnap 
(Spectronics, Westbury, NY) linked with the gel analysis software GeneTools. The intensity 
ratio of the competitor (C) to unknown target (T) multiplied by the ratio of sizes between the 
sample target and competitor (C/T/0.835) was plotted against competitor copy number on a 
double log scale and the unknown viral copy number was calculated as the point where the 
log of the ratio of competitor to unknown was zero (18). 
Statistical Analyses. Data were analyzed using analysis of variance (ANOVA, SAS Institute 
Inc., Cary, NC). For data generated from the experimental infection, line and trial replicate 
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were assumed to be fixed effects, while sire and litter were assumed to be random effects, 
and the disease traits were the dependent variables included in the model. A linear regression 
analysis was done using Statistix 7.0 (Analytical Software, Tallahassee, FL) to calculate 
Pearson correlations between the FACS results and experimental challenge clinical and 
disease trait measurements. 
RESULTS 
Means for the disease parameters that were significantly different between the two 
lines are presented in Table 1. 
Serology. All animals were serologically negative prior to challenge and the negative control 
animals remained sero-negative throughout, verifying that the animals were PRRSV-free 
when received. 
FACS Assay. As previously reported, the difference in percentage of infected MDMs 
between lines was statistically significant (p < 0.02). The FACShl line had an average of 31.8 
± 1.5 percent positive MDMs and the FACS10 line had an average of 23.0 ±1.4 positive 
MDMs. The correlation between the FACS results and disease traits are reported in the 
individual sections. 
Clinical Evaluation. Challenged animals from both lines began to show clinical signs of 
respiratory disease in addition to elevated rectal temperatures 24 hours after challenge. From 
12 to 20 DPI, temperatures and respiratory rates returned to normal. Over the 4 replicates, the 
least squares (LS) means for temperature score from 1-10 DPI were 1.6 ± 0.2 for the FACShl 
line and 2.4 ± 0.2 for the FACS10 line (p < 0.02) and from 1-20 DPI were 2.1 ± 0.3 for the 
F ACS1" line and 3.2 ± 0.3 for the FACS10 line (p < 0.02). The LS means for respiratory score 
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TABLE 1. Summary of least squares means for disease traits with significant 
differences between the FACShl and FACS10 lines over all 4 replicates.3 
Disease Trait FACShi Line FACS10 Line 
PRRSV-FACS Assay 31.8 23.0 
Respiratory Score 1-10 DPI 15.3 16.3 
Temperature Score 1-10 DPI 1.61 2.37 
Temperature Score 1-20 DPI 2.1 3.2 
Serum Virus Titer 10 DPI 104'1 10^ 
Percentage Macroscopic Lung Lesion 10 DPI 37.3 53.3 
Interstitial Pneumonia Score (0-6) 10 DPI 3.5 4.5 
Serum Virus Titer 21 DPI lO1"6 10°8 
Interstitial Pneumonia Score 21 DPI 1.7 2.0 
'p < 0.05 
for 1-10 DPI were 15.3 ± 0.3 for the FACS1" line and 16.3 ± 0.3 (p < 0.02) for the FACS10 
line. The results of the in vitro FACS susceptibility assay were shown to be significantly 
correlated with temperature score sum from 1-10 DPI with r = -0.50 (p < 0.0001), 
temperature score sum from 1-20 DPI with r = -0.43 (p < 0.0001), and with respiratory score 
sum from 1-10 DPI with r = -0.24 (p < 0.015). The remaining clinical measurements past 10 
DPI were not shown to be significantly correlated with FACS results. 
Pathological Examination. At 10 DPI, typical PRRSV macroscopic lesions were visible in 
all challenged animals, described as multifocal to diffuse tan-mottled areas and lungs that 
were firm and failed to collapse. There was visible lymph node enlargement in nearly all 
challenged animals. In addition, microscopic lung lesions typical of PRRSV were observed 
in all of the challenged animals. The LS means for percent macroscopic pneumonia were 
37.3 ± 2.9 for the FACShi line and 53.3 ± 2.6 for the FACS10 line (p < 0.001). The 
microscopic interstitial pneumonia scores were consistent with the macroscopic pneumonia 
lesions with LS means of 3.5 ± 0.2 for the FACS1" line and 4.5 ±0.1 the FACS10 line (p < 
0.001). The FACS results were shown to be significantly correlated with the macroscopic 
pneumonia scores at 10 DPI with r = -0.28 (p < 0.005), but not with microscopic interstitial 
pneumonia scores. The 21 DPI microscopic interstitial pneumonia scores had LS means of 
1.7 ± 0.1 for the FACS1" line and 2.0 ± 0.1 the FACS10 line (p < 0.03). There were no 
significant differences between lines for macroscopic lesions at 21 DPI and no other 
measurements were shown to be significantly correlated with the FACS results. 
Virus Titration. All pigs that were challenged had detectable levels of virus at 10 DPI in 
serum and BAL by both the tissue culture TCID50 method and by QC-RT-PCR. The LS 
means for TCID5o/ml serum virus titer at 10 DPI were 104'1 ±0'06 for the FACS1" line and 104'2 
±0
'
05 for the FACS10 line over all 4 replicates (p < 0.03). LS means for copy number//d in 
serum QC-RT-PCR results for replicates 2-4 at 10 DPI were io7-9±009 for the FACS1" line 
and io83±007 for the FACS10 line (p < 0.003) (Fig. 1). Serum levels of virus at DPI 10 were 
significantly correlated with the FACS results with r = -0.32 (p < 0.001) for TCID^/ml and r 
= -0.25 (p < 0.003) for QC-RT-PCR copies/jd. 
Virus titers in serum and BAL had begun to fall by 21 DPI at which point some had 
dropped below detectable levels. However, the LS means for TCIDso/ml serum virus titer at 
21 DPI were lO1'6*0'2 for the FACShi line and 10°-8±0'2 for the FACS10 line (p < 0.04). Least 
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10 DPI Serum Titer 
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Figure 1. Logio transformed serum tissue culture titer in TCID50/ml or QC-RT-PCR copy 
number per /xl at 10 DPI. The LS means for TCIDso/ml serum virus titer at 10 DPI were 104'1 
* 0 06 for the FACShl line (solid black bar) and 104'2 *0 05 for the FACS10 line (solid gray bar) 
over all 4 replicates (p < 0.03). LS means for copy number per jul in serum QC-RT-PCR 
results for replicates 2-4 at 10 DPI were io7-9±00 for the FACS1" line (hatched bar) and 108'3 
*0 07 for the FACS10 line (gray grid bar) (p < 0.003). 
squares means for serum QC-RT-PCR results in copies/^1 for replicates 2-4 at 21 DPI were 
106'6±0'35 for the FACShi line and 105'7±0'32 for the FACS10 line (p < 0.07) (Fig. 2). Neither 
the TCID50 titer nor the QC-RT-PCR copy number at 21 DPI was significantly correlated 
with the in vitro FACS results. 
DISCUSSION 
Previous work in our laboratory has demonstrated significant differences in the susceptibility 
of MDMs to PRRSV between commercial pig lines using an in vitro FACS assay (A. L. 
Vincent, B. J. Thacker, P. G. Halbur, M. F. Rothschild, and E. L. Thacker, submitted for 
publication). The purpose of this investigation was to determine if the differences 
demonstrated in vitro in the FACS1" and FACS10 lines was correlated with disease traits in 
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Figure 2. Logio transformed serum tissue culture titer in TCID50/ml or QC-RT-PCR copy 
number per ju.1 at 21 DPI. The LS means for TCID50/ml serum virus titer at were 1016 ±0'2 for 
the FACShl line (solid black bar) and xo0 8 ± 0 2 for the FACS10 line (solid gray bar) over all 4 
replicates (p < 0.04). LS means for copy number per jitl in serum QC-RT-PCR results for 
replicates 2-4 at 21 DPI were io6-6±035 for the FACS1" line (hatched bar) and io5-7±032 for 
the FACS10 line (gray grid bar) (p < 0.07). 
vivo. Significant differences between the lines were found for five variables related to disease 
severity at 10 DPI, including respiratory score sum, rectal temperature score sum, virus levels 
in serum, macroscopic lung score, and microscopic lung score. Of these traits, the 10 DPI 
respiratory score sum, rectal temperature score sum, virus levels in serum, and macroscopic 
lung score were significantly, but negatively, correlated with the in vitro MDM-FACS assay. 
The FACS10 line was consistently more susceptible to PRRSV in the early time points, 
although clinically the differences were small. Interestingly, at 21 DPI, the relationship 
reversed and the FACS10 line had significantly less viremia as measured by a tissue culture 
titration method. In addition, the difference in the means by line for QC-RT-PCR copy 
number in serum at 21 DPI was approaching significance and was supportive of the tissue 
culture titer results. It also appears that the differences in the line means were increasing at 
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the 21 DPI time point. Since PRRSV has been well documented to establish chronic, long 
term infections in a large percentage of pigs (12, 28), the results at 21 DPI may be indicative 
of a host genetic component in the establishment of persistent infections, although later time 
points would be required to support this. The existence of chronically infected animals in 
farms attempting to control or eradicate PRRSV is currently a critical issue in the swine 
industry. 
Reports in the literature on differences in susceptibility to PRRSV have been limited, 
although anecdotal reports from field observations suggest wide ranges in clinical disease 
within and between farms. The limited reports in the literature on genetic susceptibility to 
PRRSV have investigated differences between purebred lines and no evidence has been 
presented for differences in commercial crossbred lines used as breeding stock in a large 
number of swine operations around the world. Based on the in vitro and in vivo results 
described here, variability between commercial genetic lines in susceptibility to PRRSV 
appears to exist. 
The in vitro assay was shown to be inversely correlated with DPI 1-10 respiratory 
score sum, DPI 1-10 rectal temperature score sum, DPI 10 macroscopic lung lesion scores, 
and DPI 10 virus titer in serum. It should be noted that this relationship was investigated for 
one time point in vitro, 24 hours post-infection. This time point was chosen due to the limited 
number of MDMs available when produced from peripheral monocytes and the PRRSV-
induced apoptosis that occurs within 24 hours post infection in culture (19). This was 
balanced with the demonstration of peak infection levels of MDMs by flow cytometry 
between 24 and 48 hours post-infection (21). The difference in the susceptibility in the 
macrophages between the two lines at this early time point may indicate a difference in viral 
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attachment, entry, or early stages of replication without time for many host response systems 
to be activated. 
It has been shown that PRRSV has a restricted tropism for some populations of 
macrophages and different stages of activation can influence their susceptibility to the virus 
(4). Since the macrophage is a potent effector cell of the immune response, it is not clear 
what proportion of the infected macrophages in vivo would support propagation of virus 
and/or stimulate an immune response through autocrine or paracrine activation. Studies 
investigating the pathways for PRRSV infection have shown that virus attachment occurred 
in nearly all alveolar macrophages cultured with virus within 60 minutes, however, viral 
replication only appeared to occur in 30% of the cells (17). In addition, PRRSV has been 
shown to induce apoptosis primarily in uninfected bystander macrophages in vivo and in 
vitro (14, 19), which may be a protective mechanism by the host to prevent subsequent 
infection of incoming monocytes by infected resident macrophages. PRRSV has been shown 
to use sialoadhesin present on the surface of macrophages for virus entry through clathrin-
mediated endocytosis. However, the transaction of the sialoadhesin gene into a non-
macrophage cell type alone was insufficient to support uncoating and replication in the 
transfected cells (24), indicating additional steps in the infectious pathway. All of these 
factors suggest that host resistance to PRRSV is complex and a more complete understanding 
of the molecular pathogenesis of PRRSV may reveal the biologic basis for the inverse 
relationship between the in vitro assay and the disease traits at 10 DPI. 
The PRRSV-MDM FACS assay was not correlated with susceptibility on an 
individual animal basis or even within an individual replicate, as demonstrated by the large 
amount of variation in the assay between replicates (A. L. Vincent, B. J. Thacker, P. G. 
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Halbur, M. F. Rothschild, and E. L. Thacker, submitted for publication). This variation is 
most likely due to the inherent inconsistencies that are characteristic of biologic assays. To 
remove assay to assay variation, it would be beneficial to incorporate an index macrophage 
cell line to control for changes in culture conditions and inactivity of the virus. However, to 
date, continuous macrophage lines have not been shown to support PRRSV infection (27), 
and the mechanism of infection for the permissive MARC-145 cells has been shown to be 
quite different than that of macrophages (17), suggesting it would also not be a suitable index 
cell line for the PRRSV FACS assay. 
Assay variation on an individual animal basis is also likely affected by the immune 
status of the pig and age of testing, in addition to the inherent variability in the assay itself. 
The health status of the animals used in this study changed over time between replicates, but 
no other alternative animals could be used due to the requirements of specific genetic lines 
and PRRSV-free status. Study animals tested positive for Bordetella bronchiseptica, 
Pasteurella multocida, Mycoplasma hyorhinis, and porcine respiratory coronavirus. Lesions 
indicative of Mycoplasma hyopneumoniae and cytomegalovirus were also present, but the 
organisms were not isolated. The presence of these organisms is unlikely to have interfered 
significantly with the health status and thus the difference between the lines following 
PRRSV challenge since the two lines were mixed as pen-mates in the same isolation room. 
The negative control animals in each of the replicates exhibited no respiratory disease due to 
these other organisms. The health status of the challenge groups was relatively consistent and 
the presence of other organisms may represent a PRRSV challenge more typical of field 
cases. 
Identification of lines with decreased susceptibility to PRRSV-induced disease would 
be of great value to the swine industry since PRRSV has a major economic impact and has 
been difficult to manage through traditional methods that include vaccination and biosecurity 
measures. Highly virulent strains of PRRSV can cause extreme losses due to both reduced 
reproductive performance in adult animals and impaired growth and increased mortality in 
growing animals. In addition, PRRSV has been demonstrated to have an immunomodulatory 
effect through reduced vaccine efficacy to M. hyopneumortia (22) and swine influenza virus 
(E. Thacker, P. Kitikoon, A. Vincent, K. Hippie, D. Nilubol, S. Yu, B. Janke, and B.Thacker, 
4th Int. Symp. on Emerg. and Re-emerg. Pig Dis., 2003). Accordingly, low virulence strains 
may also cause economic losses due to impaired immune responses to concurrent or 
subsequent infections. 
The results reported here and elsewhere suggest that selection of pigs that possess 
increased resistance to this economically important disease should be considered. Genetic 
improvements in PRRSV resistance could be further advanced by identification of genes or 
genetic markers correlated with resistance. The characterization of sialoadhesin as a receptor 
for PRRSV or its regulatory factors may lead to potential sources of genetic variation in 
susceptibility to PRRSV. Immune responses through regulation of cell surface molecules, 
including MHC and cytokine receptors, production of cytokines and chemokines, and 
production of neutralizing antibody are other potential mechanisms in which genetic 
selection could be utilized to improve the health status of swine (5, 7, 26). Alternatively, the 
existence of lines with large differences in susceptibility may allow for development of line 
crosses that would facilitate genomic scans to identify chromosomal regions associated with 
resistance to PRRSV. If chromosomal regions can be identified for PRRSV susceptibility, 
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development of genetic markers to aid in the selection of animals with increased resistance 
may be feasible (20, 23). 
Increasing our understanding of the pathogenesis of PRRSV and the molecules 
involved in regulating the specific immune responses taking place in the host will be 
beneficial in identifying the specific genes involved. Additionally, the identification of the 
host genes involved could potentially be used to develop genetic markers that improve health 
traits of pigs. Such an understanding is fundamental for improving preventative and 
therapeutic treatments against this important pig pathogen. 
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CHAPTER 4. GENERAL CONCLUSIONS 
The goals of the investigation described herein were two-fold. The first objective was 
to evaluate the use of an antemortem in vitro assay as an indicator of genetic differences 
between commercial breeding stock lines of pigs in their susceptibility of macrophages to 
PPRSV. The second objective was to confirm the in vitro differences with an in vivo 
challenge study comparing two genetically diverse lines from the initial screening, one with a 
high percentage of infected MDMs (FACShl line) and one with a low percentage of infected 
MDMs (FACS10 line) in the flow cytometric assay. In addition, correlations between the in 
vitro flow cytometric assay and various parameters of the PRRSV-induced respiratory 
disease measured in the in vivo challenge study were evaluated. 
Five genetic lines from a single PRRSV-free farm were screened for differences in 
their average percentage of infected macrophages in the PRRSV MDM FACS assay. 
Statistically significant differences were demonstrated between genetically distinct lines of 
pigs in the initial screening, and these results were reproduced in subsequent trials on the two 
selected lines, with the F ACS1" line consistently having higher average percentages of 
infected MDMs. The percentage of infected MDMs was strongly and significantly correlated 
with the amount of viral RNA at 24 hours post infection. This suggests that a major 
difference in the in vitro susceptibility of macrophages between the two lines was in the early 
steps of the virus lifecycle such as entry and/or uncoating. This study was the first to 
describe the use of a flow cytometric assay as an indicator of genetic differences in 
susceptibility to an infectious organism in swine. More importantly, the in vitro study 
strongly indicated that differences in susceptibility to PRRSV between the two lines may 
exist in the host and may be correlated with the severity of clinical respiratory disease. 
68 
To evaluate differences in the host between the FACShl and the FACS10 lines, the pigs 
used in the follow-up in vitro study were then challenged with a virulent strain of PRRSV 
and evaluated for clinical and pathological signs of disease. Significant differences between 
the lines were found for five variables related to disease severity at 10 DPI, including 
respiratory score sum, rectal temperature score sum, virus levels in serum, macroscopic lung 
score, and microscopic lung score. Surprisingly, the 10 DPI respiratory score sum, rectal 
temperature score sum, virus levels in serum, and macroscopic lung score were significantly, 
but negatively, correlated with the in vitro MDM-FACS assay. The FACS10 line was 
consistently more susceptible to PRRSV in the early time points, although clinically the 
differences were small. Interestingly, at 21 DPI, the relationship reversed and the FACS10 
line had significantly less viremia as measured by a tissue culture titration method and was 
approaching significance in the QC-RT-PCR copy number. The differences in the line means 
appeared to be increasing at the 21 DPI time point. 
Based on the use of the in vitro assay described here, variability in susceptibility of 
macrophages to PRRSV between genetic lines exists, and the assay can be utilized to identify 
populations of genetically distinct animals with significant differences in susceptibility to 
PRRSV in vivo. The results reported here add further evidence that selection of pigs 
possessing increased resistance to this economically important disease should be considered. 
Identification of lines with decreased susceptibility would be of great value to the swine 
industry since PRRS has a major economic impact and remains difficult to manage using 
traditional methods. Although animals with complete resistant to all PRRSV isolates will 
likely be difficult to identify and/or develop, pigs with decreased clinical impact and 
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decreased transmission of virus progeny would be a tremendous advantage for swine 
producers in areas where eradication and negative status is difficult to maintain. 
The clinical differences between the two lines were unfortunately smaller than 
anticipated based on the in vitro study, and there is questionable clinical relevance of the 
differences identified between the two lines. However, the results described here provide 
evidence that genetic variation exists and further research is necessary to fully evaluate the 
flow cytometric assay and its correlation with in vivo susceptibility. The PRRSV isolate used 
in these studies was highly virulent and may have overwhelmed the potential genetic 
variability that may have been expressed with moderate to low-virulent isolates. The VR-
2385 isolate was chosen due to the existence of an established pathogenesis model used 
regularly in our laboratory and the reliable reproduction of respiratory disease in growing 
animals. However, future studies should be done to evaluate genetic differences between 
line or breeds of pigs using other isolates of PRRSV. 
Recently, the membrane protein sialoadhesin with restricted expression on 
macrophages was defined as a receptor for PRRSV entry (Vanderheijden et al., 2003). A 
monoclonal antibody was utilized to characterize this molecule and may be useful for the 
purpose of defining those subpopulations of macrophages that are susceptible to infection 
with PRRSV. If the antibody against sialoadhesin becomes available, there is potential for 
incorporating it into the existing PRRSV MDM F ACS assay to better define the proportion 
of the macrophage population that is susceptible to attachment by the virus in addition to 
supporting uncoating and replication. Furthermore, the more precise identification of 
subpopulations of macrophages susceptible to PRRSV attachment and/or infection may also 
reduce some of the assay variability, increasing its usefulness as a screening tool. Finally, 
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the 21 DPI results for virus concentration in serum in our challenge study suggest that 
additional time points between 10 and 21 DPI, and possibly beyond, should be evaluated for 
correlation with the in vitro assay. Time until viral clearance is a clinically important trait 
but was not evaluated in these investigations due to study limitations. 
Although this study strongly suggests underlying genetic variation to PRRSV 
susceptibility, much work remains before the genetic variation can be exploited to reduce the 
impact of PRRSV in the field. The most powerful strategy to address the remaining work is 
through multi-disciplinary interaction. Future challenge studies in combination with the in 
vitro assay are required to better identify lines or sires that are divergent in their 
susceptibility to PRRSV at a clinically relevant level. To complement the disease 
pathogenesis studies, research is currently underway in several laboratories to identify genes 
expressed in macrophages and lymphocytes that are up- or down-regulated in response to 
PRRSV infection. The identified genes can then be evaluated as candidate genes for control 
of infection and/or transmission in pigs characterized to have high or low susceptibility. 
Careful selection strategies might then be employed to increase the resistance of swine 
populations to this important pathogen without interfering with progress in other traits of 
importance. 
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APPENDIX A. 
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Abstract 
Two RT-PCR methods for quantification of PRRSV were developed and compared with the 
standard TCID50 tissue culture titration method. A 405 nt cRNA standard with an 80 bp 
internal deletion within ORF 7 of PRRSV strain VR-2385 was produced that was 
subsequently used as an internal competitor in QC-RT-PCR. For the quantitative real time 
RT-PCR assay, a self-quenching fluorogenic forward primer and an unlabeled reverse primer 
were designed to amplify a 74 bp fragment within the same ORF 6/7 region as the modified 
RNA standard. The 405nt cRNA was used to produce an external standard curve by plotting 
fluorescence of ten-fold serial dilutions by copy number of the cRNA standard against the 
cycle threshold number. The RT-PCR based assays were significantly correlated with one 
another and with the TCID50 method, although the correlation coefficients were moderate. 
Due to its speed and sensitivity, the real time assay was pursued to evaluate its ability to 
detect multiple sequence variants of PRRSV and its sensitivity was compared to standard 
RT-PCR. The real time assay was able to detect all isolates of PRRSV tested and had roughly 
the same sensitivity as single step RT-PCR. 
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competitive RT-PCR, real time RT-PCR 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the primary 
respiratory pathogens involved in performance and mortality losses in nursery and finisher 
pigs. In addition, PRRSV is responsible for late term abortions and reproductive losses in 
mature animals. The virus is ubiquitous in swine-producing regions around the world. In 
addition to being pathogenic itself, PRRSV also appears to interact with other respiratory 
pathogens and plays a significant contributory role in the porcine respiratory disease complex 
(PRDC) in growing animals. PRRSV is an enveloped RNA virus in the order Nidovirales, 
genus Arteriviridae. 
The PRRS virus has a positive sense RNA genome of approximately 15 kilobases 
(kb) with eight open reading frames (ORF la, lb, and 2-7) (Meulenberg, 2000). A nested set 
of subgenomic mRNAs encoding the structural proteins are produced during replication. 
Sequence comparisons between PRRSV isolates have shown a high degree of variation in the 
ORF 5 sequence, encoding the major envelope protein. However the ORF lb (replicase) and 
ORF 7 (nucleocapsid) sequences have been shown to be more conserved (Chang et al., 
2002). RT-PCR technology has become widely used for the detection of RNA viral 
pathogens, including PRRSV (Christopher-Hennings et al., 1995), however, this technique in 
itself is not quantitative. Since many PRRSV isolates do not induce cytopathic effects, the 
traditional method to quantify the amount of PRRSV is to use a fluorescent antibody assay 
on tissue culture cells inoculated with serial dilutions of the test sample to calculate the 
TCIDso (Kim et al., 1993). This technique is both time consuming and labor intensive, 
especially with large numbers of samples. It is also limited to aqueous fluids that are 
amenable to serial dilutions. 
Quantitative RT-PCR (Q-RT-PCR) should ideally control for variation in enzyme 
efficiency between samples. This includes both the reverse transcriptase and the DNA 
polymerase, as well as concentration of reagents, presence of inhibitors, or human error. 
Single step quantitative competitive RT-PCR (QC-RT-PCR) makes use of a homologous 
RNA standard that serves as an internal competitor that is reverse transcribed and amplified 
by the same primers that amplify the target piece of RNA (Freeman et al., 1999). The 
standard, or competitor, can therefore control for variability in both the RT and the PCR 
steps. The use of QC-RT-PCR has been reported for quantification of viral RNA for PRRSV 
(Shin et al., 1998), and other viruses such as HIV (Piatak et al., 1993), human hepatitis C 
(Gerken et al., 1997), avian leukosis virus (Kim et al., 2002), and many others. 
Real time PCR allows for immediate detection of amplified products through the use 
of fluorophores and eliminates the need for post-PCR detection methods (Mackay et al., 
2002). LUX primers contain a single fluorophore positioned near a 3' guanosine and are self-
quenching when they are in the form of a hairpin loop. These primers have been shown to be 
efficient reporters in real time PCR (Nazarenko et al., 2002) and have become available 
commercially. Single tube real time RT-PCR has the advantage of being more rapid, 
potentially more sensitive, having reduced risk of cross-contamination, and has the ability to 
be made quantitative with external standards. In addition, the use of the LUX primers has the 
advantage, in the case of amplifying PRRS viral RNA, of being less stringent than the primer 
and probe system and less susceptible to problems associated with PCR kinetics. 
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The objectives of this study were to develop an RNA standard from ORF 7 to be used 
in QC-RT-PCR and to develop a real time Q-RT-PCR using the LUX primer technology for 
quantification of PRRSV load that would be both sensitive and reliable for detection of 
multiple isolates of virus. Furthermore, these two detection methods were compared with the 
standard tissue culture titration method. 
Materials and Methods 
Production of in vivo viral samples and tissue culture titration 
Serum samples were from animals inoculated at approximately six weeks of age as 
previously described (Halbur et al., 1995; Halbur et al., 1998). Briefly, 5 ml of a high 
virulence strain (VR-2385) at a dosage of 106 TCIDsq/S ml was administered intranasally on 
trial Day 0. Serum and bronchoalveolar lavage (BAL) samples were collected at 10 and 21 
days post infection (DPI) and were used in the quantification assays. An aliquot of each 
serum sample was titrated in triplicate using the tissue culture method previously described 
(Kim et al., 1993, Meng et al., 1996). The presence of the virus was detected using an 
indirect immuno-fluorescence assay using a monoclonal antibody against the nucleocapsid 
protein (SDOW-17, Rural Technologies, Brookings, SD) and a goat anti-mouse IgG 
conjugated with FITC (Sigma Aldrich Corp., St. Louis, MO) was used as the secondary 
antibody. The TCID50 was calculated using the Reed-Muench accumulative method 
(Coligan, 1996). 
RNA Isolation 
Viral RNA was extracted from 140 |il of sera or BAL using a commercial kit 
(QIAamp viral RNA Mini Kit, Qiagen Inc., Valencia, CA) according to the manufacturer's 
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recommendations. Each RNA sample was eluted in 60 ^1 of the provided elutant and stored 
according to kit recommendations. 
Development of the RNA standard 
The PRRSV competitor was developed by amplifying a 485 base pair fragment of 
PRRSV isolate VR-2385 using the outer primers flanking ORF 7 (bp 14836-15320, 
accession AY150564) described by Christopher-Hennings et al (Christopher-Hennings et al., 
1995). The viral RNA was amplified using the Promega Access RT-PCR system (Promega 
Corp., Madison, WI), and each 50 ju,l reaction contained IX AMV/7)7 Buffer, 2.25 mM 
magnesium sulfate, 0.8 mM dNTP mixture, 0.5 fiM of each primer, 2.5 units Tfl polymerase, 
and 2.5 units AMV reverse transcriptase. The RT-PCR program consisted of 48°C for 30 
min; 94°C for 2 min; 34 cycles of 94°C for 15 sec, 59°C for 30 sec, and 72°C for 30 sec; and 
a final elongation step of 72°C for 7 min. An 80 base pair internal deletion in the 485 bp 
product was generated using restriction endonuclease digestion followed by ligation and 
selection of the fragment with the desired length. The 485 bp PCR product was digested with 
Hhal (Promega Corp., Madison, WI) at 37°C for 1 hr. The digestion product was purified 
using a phenol:chloroform:isoamyl alcohol (25:24:1) miniprep followed by an ethanol 
precipitation. Briefly, the digestion product was taken to 100yul volume with Tris-EDTA (TE) 
to which 50 /x, 1 of the phenol:chloroform:isoamyl alcohol was added. After vortexing, the 
mixture was centrifuged at 15,800 x g for 4 min and the upper aqueous layer was removed to 
a clean tube. The DNA was precipitated with 200 jul 95% ethanol, 10 pil 3M Sodium Acetate 
pH 5.2, and 1 fx 1 glycogen. The reaction was incubated at -20°C for 15 min, and the pellet 
was isolated by centrifugation at 15,800 xg for 10 min. The pellet was washed two times 
with 200 fil of ice cold 70% ethanol and pelleted by centrifugation at 15,800 x g for 2 min. 
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The ethanol was evaporated by drying at room temperature for 1 hr and the pellet was 
resuspended in water. The purified fragments were re-ligated in a 10 ^1 reaction using T4 
DNA ligase (Promega Corp., Madison, WI). The randomly ligated fragments were separated 
on a 2% low melt agarose gel, and the desired fragment of 405 base pairs was retrieved using 
band stab and re-amplified using the conditions described above with the exclusion of the 
reverse transcriptase in the master mix and the RT incubation step in the thermal cycler 
profile. 
The deletion fragment was then cloned using the TOPO TA Cloning kit (Invitrogen 
Corp., Carlsbad, CA) and grown up in transformed One Shot® chemically competent 
Escherichia coli on LB plates with 50 /wg/ml kanamycin and 40/xl of 50 mg/ml 5-bromo-4-
chloro-3-indolyl-P-D-galactoside (X-gal). Plasmids from kanamycin resistant white colonies 
were isolated using QIAprep spin miniprep (Qiagen Inc., Valencia, CA) and sequenced at the 
Iowa State University Sequencing and Synthesis Facility using the M13 reverse primer for 
verification of the deletion and orientation of the insert. Verified clones were propagated in 
LB broth and plasmids were isolated using the QIAprep method as above. Isolated plasmids 
were linearized using Hindlll digestion (Promega Corp., Madison, WI) at 37°C for 2 hr and 
then phenol : chloroform: isoamyl alcohol extracted as above. The cRNA competitor of 405 
nucleotides in length was produced from the linear plasmids using Ribomax in vitro 
transcription (Promega Corp., Madison, WI). Following transcription, RNase-free DNase 
(Ambion Inc., Austin, TX) was added and the reaction incubated at 37°C for 15 min. The 
RNA was isolated with the phenol : chloroform: isoamyl alcohol miniprep followed by ethanol 
extraction described above. The reaction was incubated at -20°C for 15 min, and the pellet 
was isolated by centrifugation at 15,800 x g for 10 min. The pellet was washed with 500 jj.1 
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of ice cold 70% ethanol and pelleted by centrifugation at 15,800 x g for 2 min. The ethanol 
was evaporated by drying at room temperature for 1 hr, and the pellet was resuspended in 
RNase-free TE buffer. The cRNA standard was quantified by spectrophotometry at an 
absorbance of 260 nm and serially diluted by ten-fold copy number. The 405 nucleotide 
product was used as the internal competitor for the QC-RT-PCR and as the external control 
for the real time RT-PCR. 
QC-RT-PCR 
QC-RT-PCR reactions were run in triplicate for each test serum or BAL sample with 
three different concentrations of the 405 nt competitor. Prior to running each set of samples, 
the range of competitor was established by testing a random selection of samples against a 
range of competitor concentrations from 106 to 1010 copy number per pi. The QC-RT-PCR 
reactions used the published ORF 7 outer round primers (Christopher-Hennings et al., 1995) 
and reaction conditions described above for development of the RNA standard. The reactions 
were run on 2.5% agarose gels for approximately 1 hour. The gels were stained with 
ethidium bromide and the band intensities were analyzed using the digital imaging system 
GeneSnap (Spectronics, Westbury, NY) linked with the gel analysis software GeneTools. 
The intensity ratio of the competitor (C) to unknown target (T) multiplied by the ratio of 
sizes between the sample target and competitor (C/T/0.835) was plotted against competitor 
copy number on a double log scale and the unknown viral copy number was calculated as the 
point where the log of the ratio of competitor to unknown was zero (Piatak et al., 1993). 
Real time RT-PCR 
The LUX fluorogenic primer system (Invitrogen Corp., Carlsbad, CA) was used to 
develop primers for real time RT-PCR. In this system, the fluorophore is positioned near a 
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guanosine at the 3' end of a primer that contains a short complementary sequence at the 5' 
end. The primer forms a hairpin structure that results in quenching of the fluorophore's 
emission. The fluorophore is dequenched upon synthesis of the complementary strand when 
the double-stranded PCR product is formed (Nazarenko et al., 2002). The primers were 
created using the LUX Designer on-line program (www.invitrogen.com/lux). A FAM-labeled 
LUX fluorogenic forward primer (Invitrogen Corp., Carlsbad, CA) 5'-
cactccAGAAAAGCTGTTAAACAGGGAGTG-3 ' (nucleotides 14850-14873, accession 
AY 150564) with the additional nonspecific nucleotides added to the 5' end to form the 
hairpin in lower case letters and the thymidine labeled with F AM in bold, was used for real 
time detection. The LUX forward primer and corresponding unlabeled reverse primer 5'-
TCTGCTGCTTGCCGTTGTTA-3' (nucleotides 14898-14917, accession AY150564) were 
used to produce a 74 bp product within PRRSV ORF6 and ORF 7.The LUX primers were 
designed within the 485 bp sequence used in the QC-RT-PCR, allowing the 405nt cRNA 
competitor developed above to be used as the external RNA standard in the real time 
quantitative RT-PCR assay. The cRNA standard was serially diluted by ten-fold copy 
number, and concentrations of 101 to 1010 copies/pl were run in triplicate in the real time RT-
PCR assay to determine the detection limit. 
One-tube RT-PCR was performed in duplicate for each test serum or BAL sample 
using the Brilliant® single-step QRT-PCR system (Stratagene, La Jolla, CA) with the 
following conditions in a 25 jul reaction: IX buffer, 2.5mM magnesium chloride, 0.8 jwM 
dNTP mix, 0.3 juM each primer, 0.02 U StrataScript™ reverse transcriptase, 0.05 U 
SureStart® Taq polymerase, and 2 /xl RNA template. The RT-PCR program consisted of 45°C 
for 30 min; 95°C for 10 min; and 40 cycles of 95°C for 15 sec, 63°C for 30 sec, and 72°C for 
30 sec. Acquisition of fluorescence was done after each cycle. Following the final cycle, a 
melting curve was generated. The reactions were carried out in a Rotor-Gene 4.6 real time 
thermal cycler system (Corbett Research, Mortlake, NSW, Australia). For each run, a 
standard curve with the beginning cRNA copy number/p.1 plotted against the threshold cycle 
number (Cj) was generated using ten-fold serial dilutions by copy number of the 405 nt 
cRNA standard run in duplicate. The external standard curve was used to calculate the 
starting template concentration of the test samples. The calculated concentrations for the two 
replicates were averaged to give the copy number per pii of the ORF 6/7 transcript in the 
sample when the difference between the two samples was less than one log unit. If the 
difference exceeded this limit, the results were considered questionable and the sample was 
re-tested. 
Amplification efficiency of control RNA 
The amplification efficiency of the control cRNA was compared with viral RNA in 
the real time RT-PCR. Standard curves were derived by plotting the Ct versus the dilution 
factor of ten-fold serial dilutions by copy number of control cRNA, by serial dilutions of 
viral RNA extracted from a VR-2385 virus stock previously titered to 104'6 TCID50, and by 
RNA from each of the individual serial dilutions of the VR-2385 virus stock diluted prior to 
RNA extraction. 
Comparison of sensitivity with the nested RT-PCR 
Viral RNA was extracted as above from serum of vaccinated and unvaccinated pigs 
experimentally infected with three unique, highly virulent PRRSV isolates with sequence 
homology ranging from 71.5-89.2% between one another in ORF 5 (F. Pallares, submitted). 
Ten pigs in each of six treatment groups were challenged with VR-2385, SDSU73, or Mn-
Ol-Al. In addition, 10 negative and 3 vaccine (parent isolate JA-142) control animals were 
included. Sera were collected from 73 animals on DPI 7 and 71 animals on DPI 14. 
Qualitative results were obtained for each of the inner and outer rounds of the nested PRRSV 
RT-PCR as described previously (Christopher-Hennings et al., 1995) and were compared 
with qualitative results from the real time RT-PCR. 
Statistical analysis 
Linear regression between TCID50 tissue culture titers, QC-RT-PCR, and real time Q-RT-
PCR was performed using JMP 5.0 (SAS Institute, Cary, NC) on Logio transformed data 
from the DPI 10 and DPI 21 sera and BAL. Correlation between outer round of the nested 
RT-PCR and real time Q-RT-PCR was analyzed using the McNemar test with the hypothesis 
that Q-RT-PCR was as sensitive as the outer RT-PCR. Sensitivities of both tests were also 
calculated using the nested PCR result as the "gold standard." 
Results 
Production of the RNA Standard 
Sequencing of the TOPO clones confirmed the introduction of an 80 bp internal deletion into 
the ORF 7 485 bp PRRSV PCR fragment. The conserved regions of the 405 bp fragment had 
99% homology to multiple published PRRSV sequences of North American isolates. The 
cloned standard was subsequently used to produce the cRNA competitor via in vitro 
transcription. The copy number of the competitor cRNA was calculated based on the 
molecular weight of the cRNA competitor and absorbance at 260 nm. 
QC-RT-PCR 
Co-amplification of the 405 nt competitor with the wild type 485 nt viral fragment was 
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Fig. 1. a. Agarose gel stained with ethidium bromide containing QC-RT-PCR products. Lane 
1 is 1Kb plus DNA ladder (500 bp band labeled with arrow). Lanes 2-6 are products from 
RNA isolated from a PRRSV positive serum sample with 10-fold increasing amounts (106 to 
1010 copies/jid) of the competitor cRNA, producing a 485 bp target fragment (T) and a 405 bp 
competitor fragment (C). Lane 7 is a no template control. These samples show a typical 
progressive out-competition of the target fragment by increasing copies of competitor, b. 
Standard curve plotting the log of competitor copy number against the log ratio of target to 
competitor band intensities and multiplied by 0.835. The linear equation was solved for y=0 
and was calculated to be 106'3 for this serum sample. 
demonstrated during single tube RT-PCR with progressive competition between the two 
fragments (Fig. la). The fluorescent intensity of the bands was measured using an imaging 
system linked to a computerized analysis program. The log of the ratio of the intensities of 
the competitor fragment (C) to target fragment (T) within each of the three sample replicates 
was calculated and plotted against the log of the copy number of the competitor (Fig lb). 
Since intercalation of ethidium bromide is proportional to the length of the fragment, the 
proportion of fragment length between the target and the shorter competitor must be taken 
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Fig. 2. Linear regression analysis with best fit line (solid) and 95% confidence interval for 
estimated means (dashed), a, The R2 between logio TCID50 and logio of the calculated QC-
RT-PCR quantitation was 0.4 with pc.OOOl, n=100. b. The R2 between logio TCID50 and 
logio real time quantitation was 0.42 with p<0.0001, n=100. c. The R2 between logio QC-RT-
PCR and logio of the calculated real time RT-PCR quantitation was 0.61 with p<.0001, 
n=l13. 
into account and was calculated to be 0.835 (y=log intensity (C/T/0.835)). A simple linear 
regression equation was generated for the three points and solved for y equal to zero to give 
the concentration of PRRSV RNA in the unknown sample. To evaluate the agreement 
between cell culture titration and QC-RT-PCR, the log copy number of PRRS viral RNA 
calculated from QC-RT-PCR was plotted against the logio TCID50 of the corresponding 
sample. The assays were positively correlated with an R2 of 0.40 using linear regression with 
a significance of pO.OOOl, n=100 (Fig. 2a). 
Real time RT-PCR 
The LUX primers were shown to efficiently amplify 10-fold serial dilutions of both viral 
RNA and standard cRNA, with the slopes of the standard curves being -3.20 (R2 = 0.998) 
and -3.13 (R2 = 0.9998) respectively (Fig. 3). In addition, the real time RT-PCR assay was 
shown to reliably detect standard cRNA levels down to 101 copies//xl (Fig. 4), although the 
quantification efficiency is reduced at this lower detection level. The standard curve for 
dilutions of virus followed by RNA extraction had a slope of -3.36 and R2=0.997. For the 
serum and BAL samples, a set of standards from 106 to 109 copies//xl was run with each 
experiment and used to generate a standard curve with copy number of the standard plotted 
against CT. To compare cell culture titration with the quantitative real time RT-PCR assay, 
the log copy number of PRRS viral RNA was plotted against the logio TCID50 of the 
corresponding sample. The assays were positively correlated with an R2 of 0.41 using linear 
regression with a significance of pO.OOOl, n=100 (Fig. 2b). The agreement between 
quantitation results from the QC-RT-PCR and the real time Q-RT-PCR were evaluated using 
linear regression as well, with an R2 of 0.61, pO.OOOl, n=l 13 (Fig. 2c). 
Comparison of sensitivity with RT-PCR 
Qualitative positive or negative results from real time RT-PCR were compared with the inner 
and outer round results from the standard ORF 7 nested RT-PCR (n=144). The sensitivities 
(SE) of the Q-RT-PCR and outer RT-PCR assays compared to the nested RT-PCR (gold 
standard test) were equivalent at 73.15%. The statistical analysis demonstrated that the 
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Fig. 3. Comparison of standard curves produced from 10 fold serial dilutions of cRNA 
standard (A), stock viral RNA (•), and stock virus diluted prior to RNA extraction (•) with 
log starting concentration plotted against cycle threshold (C-r). The cRNA standard and total 
PRRS viral RNA amplified with nearly equivalent efficiencies, with slopes of -3.13 and -
3.20, respectively. The serially diluted virus was not as equivalent, with a slope of -3.36, but 
this may be explained by decreased efficiency of the viral RNA extraction with decreasing 
amounts of RNA. Each serial dilution had a strong linear relationships with the Cp, with all 
>0.998. 
detection of positive animals by real time Q-RT-PCR for the 3 challenge strains evaluated 
was as sensitive as that of the outer round of RT-PCR (p<0.0001). The McNamar kappa 
value for the detection of positive animals between the two techniques was 0.48, which 
indicates moderate agreement between the two tests. 
Discussion 
A 405 nt cRNA competitor was developed to co-amplify with PRRS viral RNA using 
primers and PCR conditions previously described (Christopher-Hennings et al., 1995). The 
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Fig. 4. Graph representing the fluorescence versus PCR cycle for ten-fold serial dilutions of 
cRNA from 1010 to 101 copies/p.1. Each dilution was run in triplicate with alternating 
concentrations in black and gray with logio concentrations superimposed on each set. The 
LUX primers are capable of detecting ORF 6/7 transcripts down to 101 copies in single-tube 
real time RT-PCR. 
405 nt cRNA competitor was also used as an external standard in single tube real time RT-
PCR. The use of the cRNA standard allows for quantification of PRRSV RNA in either QC-
RT-PCR or real time Q-RT-PCR assays. These methods provide relatively rapid and 
sensitive techniques to quantify PRRS viral RNA as compared to traditional virus titration 
methods. These techniques can be used to indicate viral load in tissues, body fluids, and 
biologic assays in both experimental and diagnostic settings. 
Since the fluorescent label of the LUX primer is incorporated into one strand of the 
amplified product, this system enabled us to perform a melting curve of the RT-PCR 
products. The melting curve allows for evaluation of nonspecific products such as primer-
dimers and gives an indication of sequence differences between PRRSV isolates based on 
shifts in the melting peak of individual samples (Lowe et al., 2003). The LUX system is 
potentially more reliable for viruses capable of mutation, such as PRRSV, since there is no 
requirement for the hybridization of a labeled probe to the amplified products. The primer 
and probe method increases the number of base pairings necessary for the hybridization of all 
primers and probe, thus potentially making the efficiency more sensitive to base changes in 
the template. In addition, the relative concentrations of the forward primer, reverse primer 
and the probe have to be carefully titrated and may be more susceptible to shifts in the 
kinetics of the reaction. Although an exhaustive test against all isolates has not been done, 
the LUX primers were able to amplify four North American isolates, VR-2385, SDSU-73, 
MN-01-A1, and a European-like isolate, and three different modified live vaccine parent 
strains, VR-2332, JA-142, and Nebraska-1 (data not shown). 
There are multiple reports of detection of PRRSV using RT-PCR technology 
(Christopher-Hennings et al., 1995; Oleksiewicz et al., 1998), as well as quantitation using 
either QC-RT-PCR (Shin et al., 1998) or the TaqMan primer and probe method (Egli et al., 
2001). Conventional RT-PCR technology does not easily lend itself to quantitation, although 
the addition of an internal competitor has been shown here and by others to be a reliable 
method for determining viral load. However, this method requires three or more replicates of 
each sample to be run and requires end product analysis by gel electrophoresis and image 
analysis. Real-time technology has the advantage of speed and reduced contamination since 
reaction analysis is performed in a closed tube without the need for additional end product 
analysis as in traditional PCR techniques. The use of primers and probes in real time assays 
can be advantageous since they can be highly specific and have reportedly been used to 
differentiate between North American VR-2332 and European Lelystad PRRSV isolates 
(Egli et al., 2001). However, this specificity is a disadvantage in circumstances where 
detection and/or quantitation of a broad range of isolates are necessary. This is an issue 
especially in North America where there are many sequence variants of PRRSV circulating 
87 
with varying degrees of pathogenicity (Meng, 2000; Murtaugh et al., 1998), and may be the 
case in Europe as well (Forsberg et al., 2002; Stadejek et al., 2002). 
It has been suggested that since PRRSV produces subgenomic transcripts, the use of 
cRNA from the subgenomic ORF's in quantitative assays may not correspond to the number 
of viral genomes. In our hands, the cRNA standard compared with using diluted total viral 
RNA had equivalent efficiencies with slopes of 3.13 and 3.20, respectively. In addition, 
comparison between virus titrations and real time calculated quantities were significantly 
correlated, although the R2 was only moderate at 0.4. This indicates that sources of variation 
exist other than that explained by the relationship between the two assays and may be due to 
the difference in the units being detected. Virus titration only detects viable virus particles 
and may be more susceptible to sample handling, whereas the RT-PCR techniques detect any 
genetic material from live or nonviable virus. It is also plausible that at lower viral 
concentrations, the extraction and amplification of RNA may not be as efficient in the RT-
PCR techniques. Indeed, isolation of RNA from serially diluted virus produced a standard 
curve with a slightly different slope than serial dilutions of RNA isolated from a virus stock 
at 104'6 TCID50, with corresponding slopes of -3.36 and -3.20. However, removing the lowest 
dilution (0.4 TCID50) from the curve changed the slope to -3.23, suggesting the breakpoint of 
efficiency for our RNA extraction is somewhere between 0.4 and 4 TCID50. 
Although the real time RT-PCR assay described here for PRRSV was designed to be 
quantitative, we also evaluated the sensitivity of the assay for qualitative determination. This 
assay was equivalent in sensitivity to standard RT-PCR detection as demonstrated by 
comparing it to reactions with the outer ORF 7 primers of the nested set described by 
Christopher-Hennings, et al. (Christopher-Hennings et al., 1995). Results for specificity are 
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difficult to evaluate since the gold standard used occasionally failed to identify positive 
animals that were test positive by the real time assay. The real time assay described here 
could potentially be incorporated into a nested protocol to enhance the sensitivity, reduce 
turn-around time and eliminate the need for open tube gel electrophoresis and analysis for 
qualitative purposes. 
We have demonstrated that either of the RT-PCR assays described are suitable for 
quantitating viral load and will be useful tools in comparing vaccine efficacy, genetic 
differences in susceptibility, host immune response, and other potential applications. We 
have also demonstrated that the self-quenching fluorogenic LUX primers can be used 
efficiently for detection and quantification of virus in real time RT-PCR and may be 
advantageous for amplification of multiple sequence variants of PRRSV. The real time 
technology, due to its speed and ease of use, makes this assay an attractive tool for 
investigating host responses and mechanisms of pathogenesis for arguably the most 
important viral pathogen in the swine industry. 
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APPENDIX B. 
ESTIMATED HERITABILITY OF PRRSV-ASSOCIATED DISEASE TRAITS 
FROM SIRES OF OFFSPRING IN THE IN VIVO CHALLENGE STUDY 
Heritability (h2) was estimated from the sire variance component from disease data 
collected in the in vivo challenge study using two commercial breeding stock lines described 
in Chapter 3. The data were analyzed using analysis of variance (ANOVA, JMP 5.1, SAS 
Institute Inc., Cary, NC) using a mixed model fit with the residual maximum likelihood 
(REML) method or fit with the method of moments (MOM). Sire was analyzed as a random 
effect, and trial replicate, line, and sex were fixed effects. The disease traits from the in vivo 
PRRSV challenge study were the dependent variables. The h2 was estimated as four times 
the percent of the total variance attributed to the sire variance component. There were eleven 
sires each for line A and B for all traits, with 22 sires total. The estimated h2 for each of the 
disease traits are reported in Table 1 with both methods of estimation. Although the number 
of sires is quite low for estimating h2, there have been no published reports for h2 estimates 
for PRRS V-associated disease traits and these estimates provide some indication of the 
genetic component involved in host susceptibility to PRRSV. The results indicate moderate 
to high h2 for the flow cytometric assay (FACS) and the 21 days post infection (DPI) disease 
traits, however the earlier parameters at 10 DPI have lower h2, with the exception of viral 
RNA in serum at 10 DPI. Further investigation including additional sires, lines, and 
offspring from those sires with collected disease data is necessary to confirm these 
preliminary h2 estimates for PRRS disease traits. 
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Table 1. Estimated heritability using REML and MOM methods of estimation for PRRS 
disease traits. 
h1 
Trait REML MOM 
F ACS assay 0.44 0.43 
Macroscopic Pneumonia 10 DPI 0.12 0.14 
Microscopic Pneumonia 10 DPI 0.09 NE* 
Number Febrile Days 1-10 DPI 0.06 0.14 
Virus in Serum 10 DPI NE 0.04 
Virus in BAL 10 DPI 0.22 0.23 
Viral RNA in serum 10 DPI 0.60 0.61 
Macroscopic Pneumonia 21 DPI 0.50 0.45 
Virus in serum 21 DPI 0.61 0.65 
Virus in BAL 21 DPI 0.31 0.35 
Viral RNA in serum 21 DPI 0.78 0.78 
Viral RNA in BAL 21 DPI NE 0.12 
*NE=N on-estimable 
94 
REFERENCES CITED 
Adams, L.G. and Templeton, J.W. (1998) Genetic resistance to bacterial diseases of animals. 
Rev Sci Tech 17, 200-19. 
Albina, E., Carrat, C. and Charley, B. (1998) Interferon-alpha response to swine arterivirus 
(PoAV), the porcine reproductive and respiratory syndrome virus. J Interferon 
Cytokine Res 18, 485-90. 
Ando, A., Kawata, H., Shigenari, A., Anzai, T., Ota, M., Katsuyama, Y., Sada, M., Goto, R., 
Takeshima, S.N., Aida, Y., Iwanaga, T., Fujimura, N., Suzuki, Y., Gojobori, T. and 
Inoko, H. (2003) Genetic polymorphism of the swine major histocompatibility 
complex ( SLA) class I genes, SLA-1, -2 and -3. Immunogenetics 55, 583-93. 
Appleyard, G., Wilkie, B.N., Kennedy, B.W. and Mallard, B.A. (1992) Antibody avidity in 
Yorkshire pigs of high and low immune response groups. Vet Immunol 
Immunopathol 31, 229-40. 
Baba, T., Shiina, T., Ando, A., Imanishi, T., Matsuno, N., Skurai, E., Nagao, T., Tanaka, K, 
Gojyobori, T. and Inoko, H. (1999) Isolation and characterization of a pig major 
histocompatibility complex (SLA) class II DNA cDNA clone. Immunogenetics 49, 
915-7. 
Bautista, E.M. and Molitor, T.W. (1999) IFN gamma inhibits porcine reproductive and 
respiratory syndrome virus replication in macrophages. Arch Virol 144, 1191-200. 
Bellamy, R. (2003) Susceptibility to mycobacterial infections: the importance of host 
genetics. Genes Immun 4,4-11. 
Benfield, D.A., Nelson, E., Collins, I.E., Harris, L., Goyal, S.M., Robison, D., Christiansen, 
W.T., Morrison, R.B., Gorcyca, D. and Chladek, D. (1992) Characterization of swine 
infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet 
Diagn Invest 4, 127-33. 
Bertschinger, H.U., Stamm, M. and Vogeli, P. (1993) Inheritance of resistance to oedema 
disease in the pig: experiments with an Escherichia coli strain expressing fimbriae 
107. Vet Microbiol 35, 79-89. 
Blackwell, J.M. (1998) Genetics of host resistance and susceptibility to intramacrophage 
pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in 
north-eastern Brazil. Int J Parasitai 28, 21-8. 
95 
Blackwell, J.M., Searle, S., Mohamed, H. and White, J.K. (2003) Divalent cation transport 
and susceptibility to infectious and autoimmune disease: continuation of the 
Ity/Lsh/Bcg/Nrampl/Slcl lal gene story. Immunol Lett 85, 197-203. 
Blaha, T. (2000) The "colorful" epidemiology of PRRS. Vet Res 31, 77-83. 
Buddaert, W., Van Reeth, K. and Pensaert, M. (1998) In vivo and in vitro interferon (IFN) 
studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Adv 
Exp Med Biol 440, 461-7. 
Butler, J.E. (1998) Immunoglobulin diversity, B-cell and antibody repertoire development in 
large farm animals. Rev Sci Tech 17, 43-70. 
Chardon, P., Renard, C. and Vaiman, M. (1999) The major histocompatibility complex in 
swine. Immunol Rev 167, 179-92. 
Collins, J.E., Benfield, D.A., Christiansen, W.T., Harris, L., Hennings, J.C., Shaw, D.P., 
Goyal, S.M., McCullough, S., Morrison, R.B., Joo, H.S. and et al. (1992) Isolation of 
swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North 
America and experimental reproduction of the disease in gnotobiotic pigs. J Vet 
Diagn Invest 4, 117-26. 
Cooke, G.S. and Hill, A.V. (2001) Genetics of susceptibility to human infectious disease. Nat 
Rev Genet 2, 967-77. 
Dean, M., Carrington, M. and O'Brien, S.J. (2002) Balanced polymorphism selected by 
genetic versus infectious human disease. Annu Rev Genomics Hum Genet 3, 263-92. 
Doenhoff, M.J. (2000) The Immune System. In: R.F.E. Axford, S.C. Bishop, F.W. Nicholas 
and J.B. Owen (Eds), Breeding for disease resistance in farm animals. CABI Pub., 
Wallingford, Oxon, UK ; New York, p. 47-72. 
Edfors-Lilja, I., Gustafsson, U., Duval-Iflah, Y., Ellergren, H., Johansson, M., Juneja, R.K., 
Marklund, L. and Andersson, L. (1995) The porcine intestinal receptor for 
Escherichia coli K88ab, K88ac: regional localization on chromosome 13 and 
influence of IgG response to the K88 antigen. Anim Genet 26, 237-42. 
Edfors-Lilja, I. and Wallgren, P. (2000) Escherichia coli and Salmonella Diarrhoea in Pigs. 
In: R.F.E. Axford, S.C. Bishop, F.W. Nicholas and J.B. Owen (Eds), Breeding for 
disease resistance in farm animals. CABI Pub., Wallingford, Oxon, UK ; New York, 
p. 253-267. 
Edfors-Lilja, I., Wattrang, E., Marklund, L., Moller, M., Andersson-Eklund, L., Andersson, 
L. and Fossum, C. (1998) Mapping quantitative trait loci for immune capacity in the 
pig. J Immunol 161, 829-35. 
96 
Francis, D.H., Erickson, A.K. and Grange, P. A. (1999) K88 adhesins of enterotoxigenic 
Escherichia coli and their porcine enterocyte receptors. Adv Exp Med Biol 473, 147-
54. 
Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3, 
710-20. 
Gogolin-Ewens, K.J., Meeusen, E.N., Scott, P.C., Adams, T.E. and Brandon, M.R. (1990) 
Genetic selection for disease resistance and traits of economic importance in animal 
production. Rev Sci Tech 9, 865-96. 
Grange, P.A. and Mouricout, M.A. (1996) Transferrin associated with the porcine intestinal 
mucosa is a receptor specific for K88ab fimbriae of Escherichia coli. Infect Immun 
64,606-10. 
Grange, P.A., Mouricout, M.A., Levery, S.B., Francis, D.H. and Erickson, A.K. (2002) 
Evaluation of receptor binding specificity of Escherichia coli K88 (F4) fimbrial 
adhesin variants using porcine serum transferrin and glycosphingolipids as model 
receptors. Infect Immun 70, 2336-43. 
Halbur, P.G., Paul, P.S., Frey, M.L., Landgraf, J., Eemisse, K., Meng, X.J., Lum, M.A., 
Andrews, J.J. and Rathje, J.A. (1995) Comparison of the pathogenicity of two US 
porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad 
virus. Vet Pathol 32, 648-60. 
Halbur, P.G., Rothschild, M.F., Thacker, B.J., Meng, X.-J., Paul, P.S. and Bruna, J.D. (1998) 
Differences in susceptibility of Duroc, Hampshire, and Meishan pigs to infection with 
a high virulence strain (VR2385) of porcine reproductive and respiratory syndrome 
virus (PRRSV). J of Anim Breed and Genet 115, 181-189. 
Haldane, J.B. (1959) The theory of natural selection today. Nature 183, 710-3. 
Henryon, M., Berg, P., Jensen, J. and Andersen, S. (2001) Genetic variation for resistance to 
clinical and subclinical diseases exists in growing pigs. Anim Sci 73, 375-387. 
Hessing, M.J., Scheepens, C.J., Schouten, W.G., Tielen, M.J. and Wiepkema, P.R. (1994) 
Social rank and disease susceptibility in pigs. Vet Immunol Immunopathol 43, 373-
87. 
Hoick, J.T. and Poison, D.D. (2003) The financial impact of PRRS virus. In: J.J. 
Zimmerman, K.J. Yoon and E. Neumann (Eds), 2003 PRRS Compendium. National 
Pork Board, Des Moines, IA, p. 51-58. 
97 
Horter, D.C., Pogranichniy, R.M., Chang, C.C., Evans, R.B., Yoon, K.J. and Zimmerman, 
J.J. (2002) Characterization of the carrier state in porcine reproductive and respiratory 
syndrome virus infection. Vet Microbiol 86, 213-28. 
Hu, J., Bumstead, N., Barrow, P., Sebastiani, G., Olien, L., Morgan, K. and Malo, D. (1997) 
Resistance to salmonellosis in the chicken is linked to NRAMPl and TNC. Genome 
Res 7, 693-704. 
Janeway, C. (2001) Immunobiology : the immune system in health and disease. Garland 
Pub., New York. 
Jin, L.Z. and Zhao, X. (2000) Intestinal receptors for adhesive fimbriae of enterotoxigenic 
Escherichia coli (ETEC) K88 in swine—a review. Appl Microbiol Biotechnol 54, 
311-8. 
Kramer, J., Malek, M. and Lament, S.J. (2003) Association of twelve candidate gene 
polymorphisms and response to challenge with Salmonella enteritidis in poultry. 
Anim Genet 34, 339-48. 
Kreutz, L.C. and Ackermann, M.R. (1996) Porcine reproductive and respiratory syndrome 
virus enters cells through a low pH-dependent endocytic pathway. Virus Res 42, 137-
47. 
Lamontagne, L., Page, C., Larochelle, R., Longtin, D. and Magar, R. (2001) Polyclonal 
activation of B cells occurs in lymphoid organs from porcine reproductive and 
respiratory syndrome virus (PRRSV)-infected pigs. Vet Immunol Immunopathol 82, 
165-82. 
Le Bon, A. and Tough, D.F. (2002) Links between innate and adaptive immunity via type I 
interferon. Curr Opin Immunol 14, 432-6. 
Libert, F., Cochaux, P., Beckman, G., Samson, M., Aksenova, M., Cao, A., Czeizel, A., 
Claustres, M., de la Rua, C., Ferrari, M., Ferrec, C., Glover, G., Grinde, B., Guran, S., 
Kucinskas, V., Lavinha, J., Mercier, B., Ogur, G., Peltonen, L., Rosatelli, C., 
Schwartz, M., Spitsyn, V., Timar, L., Beckman, L., Vassart, G. and et al. (1998) The 
deltaccrS mutation conferring protection against HIV-1 in Caucasian populations has 
a single and recent origin in Northeastern Europe. Hum Mol Genet 7, 399-406. 
Lin, M., Tseng, H.K., Trejaut, J.A., Lee, H.L., Loo, J.H., Chu, C.C., Chen, P.J., Su, Y.W., 
Lim, K.H., Tsai, Z.U., Lin, R.Y., Lin, R.S. and Huang, C.H. (2003) Association of 
HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med 
Genet 4, 9. 
98 
Loemba, H.D., Mounir, S., Mardassi, H., Archambault, D. and Dea, S. (1996) Kinetics of 
humoral immune response to the major structural proteins of the porcine reproductive 
and respiratory syndrome virus. Arch Virol 141, 751-61. 
Lopez-Fuertes, L., Campos, E., Domenech, N., Ezquerra, A., Castro, J.M., Dominguez, J. 
and Alonso, F. (2000) Porcine reproductive and respiratory syndrome (PRRS) virus 
down- modulates TNF-alpha production in infected macrophages. Virus Res 69, 41-6. 
Lunney, J.K. (1994) Current status of the swine leukocyte antigen complex. Vet Immunol 
Immunopathol 43, 19-28. 
Lunney, J.K. and Butler, J.E. (1998) Immunogenetics. In: M.F. Rothschild and A. Ruvinsky 
(Eds), The genetics of the pig. CAB International, Wallingford, Oxon, UK ; New 
York, NY, USA, p. 163-198. 
Magnusson, U., Wilkie, B., Mallard, B., Rosendal, S. and Kennedy, B. (1998) Mycoplasma 
hyorhinis infection of pigs selectively bred for high and low immune response. Vet 
Immunol Immunopathol 61, 83-96. 
Mallard, B.A., Wilkie, B.N., Kennedy, B.W. and Quinton, M. (1992) Use of estimated 
breeding values in a selection index to breed Yorkshire pigs for high and low immune 
and innate resistance factors. Anim Biotechnol 3, 257-280. 
Martens, G.W., Lunney, J.K., Baker, J.E. and Smith, D.M. (2003) Rapid assignment of swine 
leukocyte antigen haplotypes in pedigreed herds using a polymerase chain reaction-
based assay. Immunogenetics 55, 395-401. 
Meier, W.A., Galeota, J., Osorio, F.A., Husmann, R.J., Schnitzlein, W.M. and Zuckermann, 
F.A. (2003) Gradual development of the interferon-gamma response of swine to 
porcine reproductive and respiratory syndrome virus infection or vaccination. 
Virology 309, 18-31. 
Meijerink, E., Fries, R., Vogeli, P., Masabanda, J., Wigger, G., Strieker, C., 
Neuenschwander, S., Bertschinger, H.U. and Stranzinger, G. (1997) Two alpha(l,2) 
fucosyltransferase genes on porcine chromosome 6ql 1 are closely linked to the blood 
group inhibitor (S) and Escherichia coli F18 receptor (ECF18R) loci. Mamm Genome 
8, 736-41. 
Mekchay, S., Ponsuksili, S., Schellander, K. and Wimmers, K. (2003) Association of the 
porcine C3 gene with haemolytic complement activity in the pig. Genet Sel Evol 35 
Suppl 1, S83-96. 
Meulenberg, J.J. (2000) PRRSV, the virus. Vet Res 31, 11-21. 
99 
Meulenberg, J.J., van Nieuwstadt, A.P., van Essen-Zandbergen, A., Bos-de Ruijter, J.N., 
Langeveld, J.P. and Meloen, R.H. (1998) Localization and fine mapping of antigenic 
sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome 
virus with monoclonal antibodies. Virology 252, 106-14. 
Molitor, T.W., Bautista, E.M. and Choi, C.S. (1997) Immunity to PRRSV: double-edged 
sword. Vet Microbiol 55, 265-76. 
Molitor, T.W., Xiao, J. and Choi, C.S. (1996) PRRS virus infection of macrophages: 
regulation by maturation and activation state. In: American Association of Swine 
Practitioners, p. 563-569. 
Murtaugh, M.P., Faaberg, K.S., Laber, J., Elam, M. and Kapur, V. (1998) Genetic variation 
in the PRRS virus. Adv Exp Med Biol 440, 787-94. 
Murtaugh, M.P., Xiao, Z. and Zuckermann, F. (2002) Immunological responses of swine to 
porcine reproductive and respiratory syndrome virus infection. Viral Immunol 15, 
533-47. 
Nelson, E.A., Christopher-Hennings, J. and Benfield, D.A. (1994) Serum immune responses 
to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J Vet 
Diagn Invest 6, 410-5. 
Opriessnig, T., Halbur, P.G., Yoon, K.J., Pogranichniy, R.M., Harmon, K.M., Evans, R., 
Key, K.F., Pallares, F.J., Thomas, P. and Meng, X.J. (2002) Comparison of molecular 
and biological characteristics of a modified live porcine reproductive and respiratory 
syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the 
vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV. J 
Virol 76, 11837-44. 
Ostrowski, M., Galeota, J.A., Jar, A.M., Piatt, K.B., Osorio, F.A. and Lopez, O.J. (2002) 
Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive 
and respiratory syndrome virus GP5 ectodomain. J Virol 76, 4241-50. 
Ottenhoff, T.H., Verreck, F.A., Lichtenauer-Kaligis, E.G., Hoeve, M.A., Sanal, O. and van 
Dissel, J.T. (2002) Genetics, cytokines and human infectious disease: lessons from 
weakly pathogenic mycobacteria and salmonellae. Nat Genet 32, 97-105. 
Peelman, L.J. (1999) [Genetic investigation of the resistance mechanisms of the pig against 
diarrhea caused by E. coli], Verh K Acad Geneeskd Belg 61, 489-515. 
Plagemann, P.G., Rowland, R.R. and Faaberg, K.S. (2002) The primary neutralization 
epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is 
located in the middle of the GP5 ectodomain. Arch Virol 147, 2327-47. 
100 
Redpath, S., Ghazal, P. and Gascoigne, N.R. (2001) Hijacking and exploitation of IL-10 by 
intracellular pathogens. Trends Microbiol 9, 86-92. 
Reiner, G., Eckert, J., Peischl, T., Bochert, S., Jakel, T., Mackenstedt, U., Joachim, A., 
Daugschies, A. and Geldermann, H. (2002a) Variation in clinical and parasitological 
traits in Pietrain and Meishan pigs infected with Sarcocystis miescheriana. Vet 
Parasitol 106, 99-113. 
Reiner, G., Melchinger, E., Kramarova, M., Pfaff, E., Butiner, M., Saalmuller, A. and 
Geldermann, H. (2002b) Detection of quantitative trait loci for 
resistance/susceptibility to pseudorabies virus in swine. J Gen Virol 83, 167-72. 
Renard, C., Vaiman, M., Chiannilkulchai, N., Cattolico, L., Robert, C. and Chardon, P. 
(2001) Sequence of the pig major histocompatibility region containing the classical 
class I genes. Immunogenetics 53, 490-500. 
Rothschild, M.F., Hill, H.T., Christian, L.L. and Warner, C.M. (1984) Genetic differences in 
serum-neutralization titers of pigs after vaccination with pseudorabies modified live-
virus vaccine. Am J Vet Res 45, 1216-8. 
Rothschild, M.F., Skow, L. and Lamont, S.J. (2000) The major histocompatibility complex 
and its role in disease resistance and immune responsiveness. In: R.F.E. Axford, S.C. 
Bishop, F.W. Nicholas and J.B. Owen (Eds), Breeding for disease resistance in farm 
animals. CABI Pub., Wallingford, Oxon, UK ; New York, p. 73-105. 
Rowland, R.R., Robinson, B., Stefanick, J., Kim, T.S., Guanghua, L., Lawson, S.R. and 
Benfield, D.A. (2001) Inhibition of porcine reproductive and respiratory syndrome 
virus by interferon-gamma and recovery of virus replication with 2-aminopurine. 
Arch Virol 146, 539-55. 
Ryan, A.M., Hutcheson, D.P. and Womack, J.E. (1993) Type-I interferon genotypes and 
severity of clinical disease in cattle inoculated with bovine herpesvirus 1. Am J Vet 
Res 54, 73-9. 
Ryan, A.M. and Womack, J.E. (1997) A molecular genetic approach to improved animal 
health. The effect of interferon genotype on the severity of experimental bovine 
herpesvirus-1 infection. Vet Clin North Am Food Anim Pract 13, 401-9. 
Saalmuller, A. (1998) Antigen-specific immune response of porcine T lymphocytes to 
various pathogens. Rev Sci Tech 17, 71-83. 
Saalmuller, A., Pauly, T., Hohlich, B.J. and Pfaff, E. (1999) Characterization of porcine T 
lymphocytes and their immune response against viral antigens. J Biotechnol 73, 223-
33. 
101 
Samsom, J.N., de Bruin, T.G., Voermans, J.J., Meulenberg, J.J., Pol, J.M. and Blanchi, A.T. 
(2000) Changes of leukocyte phenotype and function in the broncho-alveolar lavage 
fluid of pigs infected with porcine reproductive and respiratory syndrome virus: a role 
for CD8(+) cells. J Gen Virol 81 Pt 2, 497-505. 
Sellwood, R., Gibbons, R.A., Jones, G.W. and Rutter, J.M. (1975) Adhesion of 
enteropathogenic Escherichia coli to pig intestinal brush borders: the existence of two 
pig phenotypes. J Med Microbiol 8, 405-11. 
Sinkora, M., Sinkorova, J. and Butler, J.E. (2002) B cell development and VDJ 
rearrangement in the fetal pig. Vet Immunol Immunopathol 87, 341-6. 
Skamene, E., Gros, P., Forget, A., Kongshavn, P.A., St Charles, C. and Taylor, B.A. (1982) 
Genetic regulation of resistance to intracellular pathogens. Nature 297, 506-9. 
Stear, M.J., Bishop, S.C., Mallard, B.A. and Raadsma, H. (2001) The sustainability, 
feasibility and desirability of breeding livestock for disease resistance. Res Vet Sci 
71, 1-7. 
Sullivan, A.D., Wigginton, J. and Kirschner, D. (2001) The coreceptor mutation 
CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV. 
Proc Natl Acad Sci U S A 98, 10214-9. 
Sun, H.S., Wang, L., Rothschild, M.F. and Tuggle, C.K. (1998) Mapping of the natural 
resistance-associated macrophage protein 1 (NRAMPl) gene to pig chromosome 15. 
Anim Genet 29, 138-40. 
Suradhat, S. and Thanawongnuwech, R. (2003) Upregulation of interleukin-10 gene 
expression in the leukocytes of pigs infected with porcine reproductive and 
respiratory syndrome virus. J Gen Virol 84, 2755-60. 
Suradhat, S., Thanawongnuwech, R. and Poovorawan, Y. (2003) Upregulation of IL-10 gene 
expression in porcine peripheral blood mononuclear cells by porcine reproductive and 
respiratory syndrome virus. J Gen Virol 84, 453-9. 
Thacker, E., Kitikoon, P., Vincent, A., Hippie, K., Nilubol, D., Yu, S., Janke, B. and 
Thacker, B. (2003) Influence of PRRSV infection on swine influenza vaccine 
efficacy. In: 4th International Symposium on Emerging and Re-emerging Pig 
Diseases, Rome, Italy, p. 281-282. 
Thacker, E.L. (2001) Immunology of the porcine respiratory disease complex. Vet Clin 
North Am Food Anim Pract 17, 551-65. 
102 
Thacker, E.L., Halbur, P.G., Paul, P.S. and Thacker, B.J. (1998) Detection of intracellular 
porcine reproductive and respiratory syndrome virus nucleocapsid protein in porcine 
macrophages by flow cytometry. J Vet Diagn Invest 10, 308-11. 
Thacker, E.L., Thacker, B.J., Young, T.F. and Halbur, P.G. (2000) Effect of vaccination on 
the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-
induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 18, 1244-52. 
Thanawongnuwech, R., Rungsipipat, A., Disatian, S., Saiyasombat, R., Napakanaporn, S. 
and Halbur, P.G. (2003) Immunohistochemical staining of IFN-gamma positive cells 
in porcine reproductive and respiratory syndrome virus-infected lungs. Vet Immunol 
Immunopathol 91, 73-7. 
Thanawongnuwech, R. and Thacker, E.L. (2003) Interleukin-10, interleukin-12, and 
interferon-gamma levels in the respiratory tract following Mycoplasma 
hyopneumoniae and PRRSV infection in pigs. Viral Immunol 16, 357-67. 
Thanawongnuwech, R., Thacker, E.L. and Halbur, P.G. (1997) Effect of porcine reproductive 
and respiratory syndrome virus (PRRSV) (isolate ATCC VR-2385) infection on 
bactericidal activity of porcine pulmonary intravascular macrophages (PIMs): in vitro 
comparisons with pulmonary alveolar macrophages (PAMs). Vet Immunol 
Immunopathol 59, 323-35. 
Thanawongnuwech, R., Thacker, E.L. and Halbur, P.G. (1998) Influence of pig age on virus 
titer and bactericidal activity of porcine reproductive and respiratory syndrome virus 
(PRRSV)-infected pulmonary intravascular macrophages (PIMs). Vet Microbiol 63, 
177-87. 
Underbill, D.M. (2003) Toll-like receptors: networking for success. Eur J Immunol 33, 1767-
75. 
van der Waaij, E.H., Bijma, P., Bishop, S.C. and van Arendonk, J.A. (2002) Using genetic 
markers for disease resistance to improve production under constant infection 
pressure. J Anim Sci 80, 322-9. 
Van Reeth, K., Labarque, G., Nauwynck, H. and Pensaert, M. (1999) Differential production 
of proinflammatory cytokines in the pig lung during different respiratory virus 
infections: correlations with pathogenicity. Res Vet Sci 67, 47-52. 
Vanderheijden, N., Delputte, P.L., Favoreel, H.W., Vandekerckhove, J., Van Damme, J., van 
Woensel, P.A. and Nauwynck, H.J. (2003) Involvement of sialoadhesin in entry of 
porcine reproductive and respiratory syndrome virus into porcine alveolar 
macrophages. J Virol 77, 8207-15. 
103 
Verheije, M.H., Kroese, M.V., van der Linden, I.F., de Boer-Luijtze, E.A., van Rijn, P.A., 
Pol, J.M., Meulenberg, J.J. and Steverink, P.J. (2003) Safety and protective efficacy 
of porcine reproductive and respiratory syndrome recombinant virus vaccines in 
young pigs. Vaccine 21, 2556-63. 
Vezina, S.A., Loemba, H., Foumier, M., Dea, S. and Archambault, D. (1996) Antibody 
production and blastogenic response in pigs experimentally infected with porcine 
reproductive and respiratory syndrome virus. Can J Vet Res 60, 94-9. 
Vogeli, P., Bertschinger, H.U., Stamm, M., Strieker, C., Hagger, C., Fries, R., Rapacz, J. and 
Stranzinger, G. (1996) Genes specifying receptors for F18 fimbriated Escherichia 
coli, causing oedema disease and postweaning diarrhoea in pigs, map to chromosome 
6. Anim Genet 27, 321-8. 
Voicu, I.L., Silim, A., Morin, M. and Elazhary, M.A. (1994) Interaction of porcine 
reproductive and respiratory syndrome virus with swine monocytes. Vet Rec 134, 
422-3. 
Warner, C.M., Meeker, D.L. and Rothschild, M.F. (1987) Genetic control of immune 
responsiveness: a review of its use as a tool for selection for disease resistance. J 
Anim Sci 64, 394-406. 
Weiland, E., Wieczorek-Krohmer, M., Kohl, D., Conzelmann, K.K. and Weiland, F. (1999) 
Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome 
virus are more effective in virus neutralization than monoclonal antibodies to the 
GP4. Vet Microbiol 66,171-86. 
Wilkie, B.N. and Mallard, B.A. (2000) Genetic aspects of health and disease resistance in 
pigs. In: R.F.E. Axford, S.C. Bishop, F.W. Nicholas and J.B. Owen (Eds), Breeding 
for disease resistance in farm animals. CABI Pub., Wallingford, Oxon, UK ; New 
York, p. 379-396. 
Wills, R.W., Doster, A.R., Galeota, J.A., Sur, J.H. and Osorio, F.A. (2003) Duration of 
infection and proportion of pigs persistently infected with porcine reproductive and 
respiratory syndrome virus. J Clin Microbiol 41, 58-62. 
Yoon, K.J., Wu, L.L., Zimmermann, J.J., Hill, H.T. and Piatt, K.B. (1996) Antibody-
dependent enhancement (ADE) of porcine reproductive and respiratory syndrome 
virus (PRRSV) infection in pigs. Viral Immunol 9, 51-63. 
Zhang, X., Shin, J., Molitor, T.W., Schook, L.B. and Rutherford, M.S. (1999) Molecular 
responses of macrophages to porcine reproductive and respiratory syndrome virus 
infection. Virology 262, 152-62. 
104 
ACKNOWLEDGEMENTS 
I would like to thank my committee members, Drs. Brad Thacker, Pat Halbur, Max 
Rothschild, and Chris Minion for their encouragement and guidance throughout my PhD 
training. The pursuit of a concurrent DVM and PhD has been challenging for me as well as 
for those who were supporting me and waiting so patiently for the results. I have enjoyed 
interacting and learning from each of you, and you have made tremendous contributions to 
my academic and research experiences. 
Since 1997,1 have been a part of an amazing group of people led by an equally 
remarkable person. Dr. Thacker, you have mentored and supported me through my 
veterinary and graduate studies, as well as through some monumental events in my personal 
life, like the birth of Marissa. Not only have you been supportive of my student activities, 
research, and course work throughout the years, you have also been a role model, a coach, a 
leader, and a friend. You have taught me in veterinary and graduate level courses, and I have 
watched you run one of the leading swine respiratory disease laboratories in the world, in 
addition to playing an active role in graduate programs, our department, our college, the 
university, and the veterinary profession. Even with that hectic schedule, you have taken 
time to make each of your students feel valued and ensured that working in your lab 
advanced our education at whatever stage we were in. You have been understanding of 
personal issues, yet had a way of keeping me on track with my goals in mind. I hope I have 
contributed in a small way to the group in repayment for all you have done for me. 
As for the rest of the Thacker group, I give thanks to each and everyone of you who 
have helped in many, many small and big ways. Barb Erickson and Nancy Upchurch have to 
105 
be thanked individually for all the behind the scenes work they have done. I couldn't have 
done all those assays, nor would I have known where to start to plan for an animal study or a 
necropsy without Nancy. You have been a special friend to me as well. I also had lots of 
help with the animal work and I'll never forget those daily clinical observations and 
bleedings with the other students who helped me out: Trisha, Ryan, and Pete to name a few. 
To Erin, Kate, Pravina, Shan and Rit, my fellow grad students in the lab, we have become 
quite a team and I will truly miss interacting with you on a daily basis. I pass the torch and 
the "be-done-bug" and wish you all much success and happiness in the future. 
I must also give tribute to my wonderful family whose love, support, and example has 
inspired me to complete my advanced education and training. To my husband Troy, thank 
you for giving me your patience and support over all these years. We are finally to the end of 
my education! And, to our daughter, Marissa, thank you for giving me perspective on what 
is important to me at the end of the day. I love you both and look forward to the rest of our 
lives from this point forward. I also acknowledge my parents for all their years of unfaltering 
love and encouragement. You have both taught me the value of hard work and commitment 
in both career and family, and I am forever grateful for all the ways you have shown your 
love for each of us. And to my special Grandmother Baker, you are still the matriarch and 
heroine of this family whose unconditional love and gentle way has touched us all. I am 
truly lucky to have had you all in my corner! 
